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Abstract 
Our society has become increasingly sedentary, which has resulted in numerous health 
complications.  For example, there has been an increase in blood sugar regulation abnormalities, 
which can lead to pre-diabetes and eventually type 2 diabetes.  This dissertation focuses on 
working women whom, upon initial screening, demonstrated a fasting blood sugar greater than 
100 mg/dl.  The participants completed two separate trials; 1) sitting and standing while 
completing an oral glucose tolerance test at work; and 2) sitting for one week followed by 
standing for one week at work while wearing a continuous glucose monitor and an accelerometer.  
The first Manuscript (Chapter 4) summarizes a randomized, cross-over pilot study evaluating the 
acute effect of standing at work on postprandial glucose.  Results indicated elevated postprandial 
glucose while standing (Glucose iAUC = -124.9 ± 481.7, 95% CI [-386.7, 137]) relative to 
sitting.  Manuscript II (Chapter 5) summarized a repeated measures pilot study examining the 
effect of standing in the workplace on blood glucose regulation over a one week period among 
women with impaired fasting glucose.  Sedentary time significantly predicted blood glucose 
independent of physical acitivity (p = .015).  Manuscript III (Chapter 6), also a repeated measures 
study, is a brief report examining the effect of a sit-stand desk on sedentary time during the work 
day among pre-diabetic adults.  A nonsignificant reduction in sedentary time was found in the 
life, health, and combined life and health zones in the sit-stand condition relative to the sitting 
condition (life: 1.37 ± 2.77; 95% CI [-0.35, 3.08]; health: 0.55 ± 1.56; [-0.42, 1.52]; life and 
health: 1.92 ± 3.44; [-0.21, 4.05]; zone intensities are life < 2 mph, health 2-4.5 mph, and sport > 
4.5 mph).  Additional research should recruit larger sample sizes and examine the long-term 
effect of reducing sedentary time on blood glucose among working adults with impaired fasting 
glucose. 
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1.1 Background 
Traditional physical activity interventions produce beneficial effects on glucose regulation 
and diabetes management (Andrews et al, 2011; The Look AHEAD Research Group, 2010).  
These interventions also significantly increase physical activity levels, which contributes to health 
improvements among individuals with impaired glucose regulation.  In addition to traditional 
physical activity interventions, studies suggests that reducing sedentary time, time spent sitting, 
and increasing light activity (i.e. non-exercise activity thermogenesis; NEAT) can improve blood 
sugar regulation and produce beneficial changes in weight (Levine & Miller, 2006; Healy et al., 
2008).  The detrimental effects of sitting can occur independent of physical activity level (van der 
Ploeg, Chey, Korda, Banks, & Bauman, 2012).  While increasing physical activity is an effective 
method for reducing disease risk, the problem with previous lifestyle intervention studies is that 
they have several components, are expensive, and may not translate well to the real world.   
 
1.2 Rationale 
This dissertation will address the following gaps in the literature regarding the effect of sitting on 
health outcomes:   
1. Minimal published literature analyzes the acute effect of reducing sedentary time on 
blood sugar among pre-diabetic adults. Studies examining employee wellness programs 
have targeted healthy adults or those with chronic disease but not pre-diabetic adults 
specifically.  Additional studies have examined variations of sit-stand desks in the 
workplace but again, a pre-diabetic population has not been studied utilizing this 
approach.   
2. The literature contains limited studies evaluating the acute effect of light activity (i.e., 
standing) on blood sugar regulation in pre-diabetic women.  There are no published 
studies evaluating postprandial glucose responses to standing vs. sitting among pre-
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diabetic women.  Research suggests that reducing sedentary time and incorporating 
frequent breaks could produce beneficial health outcomes including improved blood 
glucose regulation, reduced CVD risk, and reduced inflammatory biomarkers (Owen, 
Healy, Matthews, & Dunstan, 2010).   
3. Finally, continuous glucose monitoring technology has not been utilized in the pre-
diabetic population and therefore, the current studies will inform future research that aims 
to prevent the progression of pre-diabetes to type 2 diabetes.  Thus, the manuscripts will 
add to the growing literature examining the effect of sit-stand desks on reducing 
sedentary time in the workplace, but specifically among pre-diabetic adults. 
The purpose of this dissertation was to examine the effect of a sit-stand desk on blood 
glucose and sedentary time among prediabetic women.  The sit-stand desk was the primary 
intervention tool, which was installed or was already at the participant’s workplace for the 
intervention period.  The purpose of the sit-stand desk was to increase light intensity activity, 
reduce sitting time, and reduce sedentary time at work.  The desk is designed for working in a 
seated or standing position and is ergonomically correct in both positions.  The workplace was a 
logical target for reducing sedentary time considering that many full-time employees spend three 
to five  hours of their day sitting (Jans, Proper, & Hildebrandt, 2007; Brown, Miller, & Miller, 
2003).  A brief intervention that promotes reductions in sedentary time and increases in NEAT 
(i.e., light activity) has the potential to increase energy expenditure and improve blood glucose 
regulation.  
The manuscripts within this dissertation are the first, to my knowledge, to examine the 
acute effects of a sit-stand desk intervention to reduce blood glucose and sedentary time among 
pre-diabetics in the workplace.  The first manuscript evaluates the effect of a sit-stand desk on 
postprandial glucose during an oral glucose tolerance test (Specific Aim 1; Chapter 4).  The data 
was collected from adults who spent the majority of their day sitting at their job.  The participants 
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were recruited from Fairview Health Services and from the Minnesota Department of Human 
Services.  The second manuscript investigates the effect of using a sit-stand desk for an entire 
working week on blood sugar regulation in pre-diabetic adults (Specific Aim 2; Chapter 5).  The 
data for the second manuscript was collected from the same pre-diabetic adults that participated 
in the oral glucose tolerance test.  The third manuscript examines the effect of a sit-stand desk on 
sedentary time at work relative to a traditional desk (Specific Aim 3; Chapter 6).  The data for the 
final manuscript was collected concurrently from the participants who provided data in the 
second manuscript.   The specific aims and hypotheses for the manuscripts are summarized 
below. 
 
1.3 Specific Aims and Hypotheses 
Specific Aim 1: To examine the acute effect of using a sit-stand desk at work on postprandial 
glucose among pre-diabetic adults.   
Related hypothesis.  Participants will exhibit lower postprandial glucose levels when 
using a sit-stand desk when compared to a traditional desk.   
Specific Aim 2: To examine the effect of using a sit-stand desk at work on blood glucose control 
among pre-diabetic adults.   
 Related Hypothesis.  Participants will exhibit improved blood glucose regulation when 
using a sit-stand desk when compared to a traditional desk.   
Specific Aim 3: To examine the effect of using a sit-stand desk at work on sedentary time among 
pre-diabetic adults.   
Related Hypothesis.  Participants will engage in less sedentary time when using a sit-
stand desk when compared to a traditional desk.   
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2.1 Introduction 
2.1.1 Prevalence of Blood Sugar Regulation Dysfunction 
Diabetes has reached epidemic proportions in the United States and worldwide. The 
World Health Organization (WHO) reports 346 million people worldwide have diabetes (WHO, 
2011). Type 2 diabetes accounts for 90% of these individuals. In the United States alone, the 
number of people with diabetes has recently risen to 25.8 million along with an estimated 79 
million afflicted with pre-diabetes (defined as blood sugar levels above normal but not at the 
diagnostic criteria; Centers for Disease Control and Prevention [CDC], 2011).  In 2010, 1.9 
million individuals were newly diagnosed with diabetes (CDC, 2011).  Diabetes is the seventh 
leading cause of death and a chief cause of heart disease and stroke, kidney failure, lower limb 
amputations and new cases of adult blindness (CDC, 2011). Diabetes also leads to conditions 
such as retinopathy, neuropathy, hypertension, dental disease, pregnancy complications, 
depression, decreased quality of life, and susceptibility to other illnesses (CDC, 2011). The 
overall risk of death among diabetics is two times greater than their non-diabetic counterparts 
(CDC, 2011).  A low level of physical activity and obesity are two of the primary risk factors and 
predictors for the development of diabetes (USDHHS, 2008).  The literature review will outline 
the current knowledge related to the following:  (1) Physical inactivity and blood sugar regulation 
(Part 1); (2) sedentary behavior and physical inactivity physiology (Part 2); and (3) continuous 
glucose monitoring (Part 3).   
Part 1: Physical Inactivity and Blood Sugar Regulation 
2.2 Prevalence of Physical Inactivity 
The recent data on leisure-time physical activity levels in the United States indicate that 
in many parts of the nation more, than 30% of adults do not participate in any leisure-time 
physical activity (CDC, 2009).  The current data demonstrates age-adjusted rates for leisure-time 
physical inactivity range from 10% to 43% in US counties (CDC, 2008).  High levels of 
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diagnosed diabetes and obesity are also prevalent in the counties representing the high end of the 
spectrum.  According to the World Health Organization (WHO), 50% of women and 40% of men 
are not achieving the recommended levels of physical activity (WHO, 2008).  Additionally, a 
study examining physical activity using an objective measure (i.e., the ActiGraph) found that less 
than 5% of adults participated in the recommended 30 minutes of moderate-intensity physical 
activity on five or more days a week (Troiano et al., 2007).  The results of this study suggest that 
the self-reported activity levels from the CDC and WHO are underestimating physical inactivity 
levels. 
Physical inactivity is one of the primary risk factors for the development of type 2 
diabetes (American Diabetes Association [ADA], 2011).  Studies have shown that regular 
physical activity can prevent or delay the onset of type 2 diabetes among pre-diabetic individuals 
(CDC, 2011).  Similarly, physical activity is effective in the management and control of blood 
glucose regulation among type 2 diabetics (Boule, Haddad, Kenny, Wells, & Sigal, 2003).  
Physical activity is beneficial to overall health and reduces the risk of numerous adverse co-
morbid health conditions in type 2 diabetics.  Reductions in the risk of premature death, heart 
disease, stroke, hypertension, high cholesterol, metabolic syndrome, breast and colon cancer, and 
weight gain are benefits derived from regular physical activity (USDHHS, 2008). Physical 
activity has both acute and chronic effects on blood glucose regulation.   
2.2.1 Acute and Sustained Effect of Physical Activity on Blood Sugar Regulation 
The primary acute effect of physical activity on blood glucose regulation is induced by 
muscle contraction and the glucose transporter GLUT-4.  The up-regulation of GLUT-4 
translocation during muscle contraction and subsequent insulin-independent glucose uptake is the 
primary adaptive response to acute activity (Dela et al., 1994).  Although acute activity has 
beneficial effects on blood glucose control, a study noted that a single acute bout of exercise will 
not improve glucose tolerance in insulin-resistant diabetics (Rogers et al., 1988).  As few as seven 
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consecutive days of vigorous exercise was shown to be effective in reducing insulin resistance 
and improving glucose tolerance (Rogers et al, 1988).  The beneficial effects of an acute bout of 
activity in type 2 diabetics have been shown to persist into the post-exercise period (Minuk, 
Vranic, Marliss, & Hanna, 1981).  An acute bout of activity leads to heightened insulin sensitivity 
immediately after activity and up to 20 hours after activity (Minuk et al., 1981; Devlin, Hirshman, 
Horton, & Horton, 1987 
The acute benefits of physical activity are clear but it is less clear whether or not these 
acute effects translate into lifelong benefits.  Specifically, the improvements in blood glucose 
control decline within 72 hours of the last activity session underscoring the necessity for chronic 
physical activity to prevent and control type 2 diabetes (Schnieder, Amorosa, Khachadurian, & 
Ruderman, 1984).  Sustained physical activity is important due to the inverse relationship 
between fitness levels and mortality across levels of glycemic control (Kohl, Gordon, Villegas, & 
Blair, 1992).  Sustained physical activity leads to a decreased hormonal response to submaximal 
exercises, which results in glucoregulatory hormones such as glucagon and catecholamines being 
released in smaller amounts.  In addition, insulin levels do not fall as far at the onset of activity, 
which leads to an improved blood glucose level in a trained individual during activity (Brooks et 
al., 2005).  Sustained physical activity also leads to improved utilization of free fatty acids (FFA) 
and gluconeogenesis, which results in enhanced blood glucose regulation.  Moreover, research 
indicates that slow-twitch muscles have more GLUT-4 glucose uptake capacity making this 
oxidative muscle more efficient at utilizing glucose during physical activity even in the face of 
declining insulin (Kern et al., 1990).  In addition to the acute effects of exercise on diabetes, it is 
important to examine the effect of exercising over time on type 2 diabetes.  Below summarizes 
the observational and experimental studies examining this research question.   
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2.3 Observational Studies 
Observational studies have investigated the association between physical activity and the 
risk of developing diabetes.  For example, an early study conducted by Helmrich et al. (1991) 
assessed self-reported physical activity among 5,990 initially non-diabetic men.  The participants 
were followed for incidence of diabetes from 1962 to 1976.  Among these men, 202 developed 
diabetes during this period.  The results suggested that vigorous activity was most effective for 
decreasing the risk of diabetes; however, moderate intensity activity was also effective.  
Specifically, the results indicated a 6% reduction in the risk of diabetes for each 500 kilocalories 
(kcals) of self-reported leisure-time physical activity reported per week (Helmrich et al., 1991). 
The results also demonstrated a relationship between the amount of physical activity and age-
adjusted incidence of diabetes.  There was an inverse relationship between diabetes incidence and 
the amount of vigorous sports activity and moderate intensity physical activity.  This inverse 
relationship was slightly stronger for the vigorous intensity activity (Helmrich et al., 1991).  The 
protective effect of physical activity was more pronounced in men at higher risk than the men at 
lower risk for developing diabetes suggesting the importance of targeting high risk groups for 
prevention.  The beneficial effects of physical activity were independent of age, familial history 
of diabetes, obesity, and hypertension (Helmrich et al., 1991).   
Additional observational prospective cohort studies were conducted by Manson and 
colleagues (Manson et al., 1991; Manson et al., 1992).  The first study included non-diabetic, 
female registered nurses (n=87,253) followed for eight years.  The women were asked about their 
physical activity participation and then followed to measure incidence of diabetes.  After eight 
years of follow-up, the women who participated in vigorous physical activity at least one time per 
week had a 33% reduction in their age-adjusted risk of developing diabetes (p<0.0001; Manson et 
al., 1991).  The second study was a prospective cohort study of United States male physicians 
(n=21,271) from the Physician’s Health Study (Manson et al., 1992).  The participants responded 
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to questionnaires assessing the frequency of participation in vigorous physical activity and other 
health-related variables.  After five years of follow-up, the results indicated an inverse 
relationship between physical activity and diabetes risk.  Specifically, compared to sedentary 
men, the age-adjusted relative risk among men who exercised vigorously at least once a week was 
0.64 (p=0.0003; Manson et al., 1992).  The study also reported that, “A dose-response gradient of 
increased exercise with decreased risk of NIDDM was observed (Manson et al., 1992).”  Among 
those who exercised five times or more per week, there was a 42% reduction in the age-adjusted 
risk of diabetes compared to participants who exercised less than once a week (Manson et al., 
1992).  The findings from these two studies are consistent with the findings of Helmrich et al. 
(1991).  Taken together, there is fairly strong evidence based on observational data of an inverse 
relationship between physical activity and the incidence of diabetes. 
2.4 Intervention Studies 
Given the effect of physical activity on both the prevention and treatment of Type 2 
diabetes, several studies have examined the efficacy of lifestyle interventions for Type 2 pre-
diabetics and diabetics.  A majority of the studies have examined both physical activity and diet 
and therefore, studies including diet in addition to physical activity will be reviewed.  One of the 
largest lifestyle intervention trials was the Look AHEAD trial, which targeted type 2 diabetics 
(The Look AHEAD Research Group, 2010).  Specifically, 5,145 overweight and obese type 2 
diabetic participants from multiple centers were recruited for the study.  The primary aim of the 
study was to evaluate the long-term effects of an intensive lifestyle intervention.  The trial 
included an intensive lifestyle intervention group (ILI) and a diabetes support and education 
(DSE) group.  The ILI group intervention included a diet reformation which involved a reduction 
in daily caloric intake, liquid meal replacements, and a portion-controlled diet (The Look 
AHEAD Research Group, 2010).  Participants were instructed to engage in at least 175 minutes 
of physical activity per week.  Their goal was to lose 7% of their body weight by the first year 
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and to maintain this during the following years.  The ILI group also contained a behavioral 
component that emphasized self-monitoring, goal setting, and problem solving for diet and 
physical activity.  In contrast, the control DSE group was offered three group sessions each year.  
Standardized information was presented at these group sessions including diet, physical activity, 
and social support; however, no information regarding behavioral strategies was presented. 
The ILI group exhibited greater improvements in fitness, weight, blood pressure, 
glycemic control, and HDL and TG levels than the DSE group (The Look AHEAD Research 
Group, 2010).  The greatest changes from baseline were seen at year one follow-up; however, the 
ILI group continued to maintain greater changes compared to baseline than the DSE group at one 
year.  The ILI group also had a greater percentage of participants who met the ADA goal for 
HbA1c levels when compared to the DSE group.  Fitness levels increased among the ILI group 
and were maintained at a higher level compared to previous lifestyle interventions.  Weight loss 
was also higher when compared to previous studies (The Look AHEAD Research Group, 2010). 
One strength of the trial was that it was conducted in multiple centers across the country.  
However, there are several limitations related to its generalizability including the use of liquid 
meal replacements and the intensive nature of the interventions.  During the first 6 months, 
participants met weekly for three group sessions and participated in one individual session per 
month.  These sessions were led by an intervention team that included registered dieticians, 
behavioral psychologists, and exercise specialists.  One limitation is that which intervention 
strategies mediated the effect of the intervention on the outcomes was not examined.  Therefore, 
it is unclear if changes in diet or physical activity accounted for the reduction in risk factors.  The 
ILI has the potential to be implemented at the community level; however, it would be costly and 
labor intensive.  
The Early ACTID trial was a randomized controlled trial evaluating the effect of diet or 
diet plus physical activity versus a usual care group on blood glucose control and blood pressure 
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(Andrews et al., 2011).  The trial included 593 adults diagnosed with type 2 diabetes within the 
previous 5-8 months. The intensive diet intervention received dietary consultation every three 
months and monthly nurse support.  The diet plus physical activity received the same intervention 
as the diet group plus a pedometer-based activity program (Andrews et al., 2011).  The control 
group received a dietary consultation and follow-up at six months. 
Results indicated that at six months, HbA1c had improved significantly in the diet and 
diet plus physical activity groups compared to the control group.  There were no significant 
differences between the two active intervention groups (diet HbA1c -0.28% p=0.005; diet plus 
physical activity HbA1c -0.33% p<0.001; Andrews et al., 2011).  Improvements in weight and 
insulin resistance were also seen in the diet and diet plus physical activity groups relative to 
control but no differences were found between the two active arms of the study.  The practical 
implications of the study are that early diet intervention in recently diagnosed type 2 diabetics 
greatly improves blood glucose control over a one year period compared to a control group 
(Andrews et al., 2011). 
One limitation is that this study did not use theory-based behavioral strategies to increase 
physical activity among the participants.  The participants in the intensive activity and diet 
intervention increased their steps per day by 17% from 6399 to 7680 (Andrews et al., 2011).  
However, the addition of physical activity to the intensive diet intervention produced no 
additional benefit suggesting that greater increases in physical activity are needed.  Perhaps a 
theory-based intervention focusing on physical activity would have produced greater increases in 
physical activity.  Therefore, this study did not effectively test the effect of physical activity on 
Type 2 diabetes.  Another limitation is that many individuals altered their diabetic medications 
during the study.  Further research is needed to determine the dose and modality of exercise that 
is needed along with diet changes to treat type 2 diabetics.   
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Kahleova and colleagues (2010) conducted a study examining the efficacy of a vegetarian 
diet and physical activity for treating type 2 diabetes.  Seventy-four participants were randomly 
assigned to either a vegetarian diet or a conventional diabetic diet alone and then in combination 
with physical activity.  The meals for the vegetarian and control interventions were provided.  
The meals were isocaloric and both groups had a caloric restriction of 500 kcals based on the 
measurement of the individual’s resting energy expenditure.  During the initial 12 weeks of the 
study, the experimental and conventional diet groups received the diet intervention alone.  
Following the first 12 weeks, both arms of the study received a 12-week physical activity 
intervention in addition to the experimental or conventional diet. The experimental group 
exhibited greater reductions in body weight, waist circumference, visceral and subcutaneous fat, 
and oxidative stress markers than the control group.  There was also a significant reduction in 
HbA1c in the experimental group from baseline to 24 weeks relative to the control.  Physical 
activity augmented the reductions in HbA1c in the experimental group but not in the control 
group.  Visceral and subcutaneous fat decreased significantly in the experimental group with the 
addition of physical activity (4% and 2% respectively, p<0.05; Kahleova et al., 2010) but 
increased in the control group.  Therefore, it appears that diet changes were necessary to produce 
a beneficial effect of exercise.  Specifically, the only reduction in HbA1c was in the experimental 
group and this occurred in the latter 12 weeks of the intervention suggesting a benefit of physical 
activity in the reduction of the HbA1c.   
Limitations of the study include the use of provided meals.  This strategy is not 
representative of interventions occurring in the real world nor would they be sustainable in the 
long run.  This protocol attempts to control caloric intake; however, it is possible that participants 
chose to consume more than the metabolically controlled meals.  Another limitation is that 
participants self-reported their physical activity and no objective measure of physical activity was 
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used.  It is also possible that the short duration of the study may have blunted the possible effects 
of exercise in the control group.   
A six-year randomized controlled clinical trial was conducted among individuals with 
impaired glucose tolerance (IGT) in Da Qing, China (n=577; Pan et al., 1997).  The previous 
studies identified the increased risk of diabetes among high risk individuals and therefore, this 
intervention was targeted to those at high risk with IGT.  High risk participants with IGT were 
randomized to one of four conditions including:  (1), diet; (2), exercise; (3) diet plus exercise 
group; or (4) control.  At six years, cumulative incidence rates of diabetes were 67.7% in the 
control group, 43.8% in the diet group, 41.1% in the exercise group, and 46% in the diet and 
exercise group (Pan et al., 1997).  When baseline body mass index (BMI) and fasting glucose 
were controlled, the intervention groups still maintained significant reductions in their risk of 
developing diabetes.  The exercise group was associated with a 46% reduction, the diet and 
exercise group had a 42% reduction, and the diet only group had a 31% reduction in the risk of 
developing diabetes (Pan et al., 1997).  The diet and diet plus exercise groups were associated 
with significant risk reductions.  Cumulative incidence rates of diabetes were the lowest in the 
diet plus exercise group and this group exhibited the greatest risk reduction compared to the other 
groups.  These interventions, especially the diet plus exercise condition, led to significant 
reductions in the risk of developing diabetes in a high risk population. 
A similar intervention was conducted in Finland in which overweight, middle-aged 
participants (n=522) with IGT were assigned to a control or lifestyle intervention group 
(Tuomilehto et al., 2001).  The average follow-up was three years and the cumulative incidence 
of diabetes after four years was 23% in the control group and 11% in the intervention group 
(Tuomilehto et al., 2001).  The intervention group exhibited a 58% reduced risk of developing 
diabetes during the study (Tuomilehto et al., 2001).  More specifically, those who attained the 
target level of approximately four hours of moderate intensity physical activity per week had a 
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70% lower risk of developing diabetes compared to the control group (Tuomilehto et al., 2001). 
These reductions in risk are even greater than those found in the Pan et al. (1997) study and 
indicate the importance of physical activity for preventing diabetes. 
In the US, a similar diabetes prevention trial was conducted among 3,234 participants 
with IGT (Diabetes Prevention Program Research Group [DPP], 2002).  The participants were 
randomized to a placebo group, a metformin group, or a lifestyle intervention program.  The goals 
of the lifestyle intervention program were to reduce body weight by 7% and to accumulate at least 
150 minutes of physical activity per week.  The results in the intervention group were identical to 
the Finnish study in that the experimental group exhibited a 58% reduction in the risk of 
developing diabetes compared to the placebo group (DPP, 2002).  Specifically, the metformin 
group had a 31% risk reduction and the lifestyle group had a 58% risk reduction (DPP, 2002).  
The DPP demonstrated that a lifestyle intervention was effective at reducing the progression of 
IGT to overt diabetes.  Physical activity and weight reduction resulted in a decreased risk of 
diabetes development.  The lifestyle intervention was even more effective than the metformin 
intervention. 
2.5 Physical Activity Intensity and Dose 
The previous research reviewed suggests that there may be an intensity and/or dose-
response relationship between physical activity and the development of diabetes.  The previously 
mentioned Manson et al. (1991, 1992) articles reported that women who exercised vigorously at 
least once a week had a 33% reduction in the risk of diabetes (Manson et al., 1991; Manson et al., 
1992).  The study among the male physicians also reported a greater reduction in risk with 
vigorous activity but those who participated in moderate-intensity activities also experienced a 
reduction in risk.  The inverse association between physical activity and diabetes found in this 
study does suggest that benefits can still be attained at lower intensities and dose of physical 
activity. 
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A study by Lynch and colleagues (1996) examined the association between physical 
activity intensity and the incidence of diabetes (Lynch et al., 1996).  The results of this study 
suggested that moderate-intensity physical activity of at least 5.5 metabolic units (METS) and 40 
minutes in duration are necessary to reduce the risk of type 2 diabetes (Lynch et al., 1996).  This 
protective effect was not attained at intensities less than 5.5 METS regardless of the duration.  In 
a sub-group of men at high risk for the development of diabetes, the effect was even more 
prominent.  Similar results were found by Wei and colleagues (1999) who demonstrated the 
importance of moderate and higher cardiorespiratory fitness levels in the prevention of diabetes 
(Wei, Gibbons, Mitchell, Kampert, Lee, & Blair, 1999).  The results of this study suggest that 
chronic, moderate and vigorous-intensity physical activities that produce higher levels of 
cardiorespiratory fitness are essential in the prevention of diabetes. 
In slight contrast, a study was conducted among Australian men and women examining 
the relationship between sedentary time, light-intensity, and moderate to vigorous-intensity 
physical activity on two-hour plasma glucose (Healy et al., 2007).  The results revealed a positive 
association between sedentary time and two-hour plasma glucose while light, moderate, and 
vigorous-intensity physical activity were negatively associated with two-hour plasma glucose 
(Healy et al., 2007).  In addition, the association between light-intensity physical activity and 2-
hour plasma glucose remained significant when moderate to vigorous intensity activity was 
controlled for (Healy et al., 2007).  These data suggest that light-intensity physical activity may 
lead to enhanced blood glucose regulation and that replacing sedentary time with light-intensity 
activity can be effective in reducing the risk of type 2 diabetes and controlling blood sugar.  The 
negative association between two-hour plasma glucose and higher intensity activity does provide 
consistent support for the benefit of moderate to vigorous-intensity activity in the management of 
blood sugar dysfunction. 
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Similar to these results, another study reported that sedentary time predicted levels of 
fasting insulin independent of the amount of moderate to vigorous-intensity physical activity 
(Helmerhorst, Wijndaele, Brage, Wareham, & Ekelund, 2009). Results from both of these studies 
suggest that sedentary time is just as important as the time spent accumulating light, moderate, 
and vigorous-intensity physical activity.   
In the Nurse’s Health Study, the benefit of walking was compared to vigorous physical 
activity for the risk of developing diabetes (Hu et al., 1999).  Vigorous and moderate-intensity 
activities resulted in similar significant reductions in diabetes risk.  The age-adjusted relative risk 
for diabetes progressively decreased as physical intensity increased.  These results were 
independent of BMI and indicated that faster walking paces were associated with greater 
reductions in the risk of diabetes (Hu et al., 1999).  Physical activity interventions have focused 
on increasing physical activity bouts and intensity however, few, if any, have primarily focused 
on decreasing sedentary time to promote increased energy expenditure through all daily activities 
other than exercise or, non-exercise activity thermogenesis (NEAT).  
Part 2: Sedentary Behavior and Physical Inactivity Physiology 
2.6 Non-Exercise Activity Thermogenesis and Sedentary Behavior 
 Physical activity research has recently shifted to becoming increasingly aware of the 
effect of sedentary time (Healy et al., 2008).  Physical activity and sedentary time are two 
separate constructs with independent effects on energy expenditure and the disease process.  The 
number of calories burned in a day can vary greatly depending on the activities chosen to replace 
sedentary time with NEAT.  NEAT is defined as the energy expenditure of all daily activities 
other than exercise (Levine, Vander Weg, Hill, & Klesges, 2006).  There are three primary forms 
of energy expenditure; 1) the basal metabolic rate; 2) NEAT; and 3) physical activity/exercise.  
Examples of NEAT activities include walking, standing, stair climbing, dancing, and fidgeting.   
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Sedentary behavior and reductions in NEAT have been found to be risk factors for 
cardiovascular disease (CVD) and to have detrimental associations with related biomarkers for 
CVD risk (Owen, Healy, Matthews, & Dunstan, 2010).  A cross-sectional analysis of the US 
National Health and Nutrition Examination Survey (NHANES) revealed unfavorable linear 
associations between sedentary time and waist circumference, HDL, C-reactive protein, insulin, 
triglycerides, HOMA-%B, and HOMA-%S (Healy, Matthews, Dunstan, Winkler, & Owen, 
2010).  Actigraph accelerometers were used to measure activity levels.  These findings were 
independent of moderate-vigorous physical activity levels and potential confounders.  Frequent 
breaks in sedentary time were positively related to waist circumference and C-reactive protein 
(Healy et al., 2010).  This objectively-measured data demonstrates the beneficial effects of 
breaking up sedentary time to promote reductions in CVD risk factors and inflammatory 
biomarkers. 
Obese individuals are sedentary for at least 2.5 hours more and expend 350 kilocalories 
less than their lean counterparts per day (Levine et al., 2006).  Levine and colleagues (2007) 
examined levels of free-living walking among obese and lean participants and found that lean 
participants walked, on average, 3.5 miles more per day than the obese participants (Levine et al., 
2007).  Additional research has shown that frequent breaks in sedentary time resulted in 
significant benefits for changes in waist circumference, BMI, triglycerides, and 2-hour plasma 
glucose (Healy et al., 2008).   
These studies suggest that increases in NEAT and reductions in sedentary time lead to 
increased total daily energy expenditure, which has led to improvements in anthropometric 
measurements and metabolic risk markers.  They also suggest that light-intensity physical activity 
is associated with improvements in blood glucose regulation while sedentary time is negatively 
associated with blood glucose regulation.  Frequent, short-duration, light-intensity activity and 
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reductions in sedentary time have the potential to improve blood glucose regulation among type 2 
diabetics. 
 Levine and Miller (2006) conducted a study utilizing walk-and-work desks in an 
occupational setting among obese workers (Levine & Miller, 2006).  Participants worked on their 
computer while walking on a treadmill at a self-selected pace.  Energy expenditure was measured 
at rest, seated and working, standing, and walking while working.  The mean increase in energy 
expenditure using a walking while working desk was 119 kcals/hour (Levine & Miller, 2006).  
Therefore, this rate of daily energy expenditure performed 2-3 hours per day with other 
components remaining constant, could result in a 20-30 kg/year weight loss (Levine & Miller, 
2006).  This article provides an example of the potential for weight loss produced by increasing 
NEAT and light-intensity activity.  Although walk-and-work desks may not be feasible, 
increasing NEAT can lead to increased total daily energy expenditure and subsequent weight loss.  
The literature is not; however, conclusive to suggest that increasing NEAT and reducing 
sedentary time is sufficient enough to produce the cardiovascular and metabolic improvements 
associated with moderate and vigorous intensity exercise.   
 Energy expenditure was examined in a simulated classroom setting.  The effect of sitting 
versus standing on caloric expenditure was examined in young, healthy participants (n=10 male, 
n=10 female; Reiff, Marlatt, & Dengel, 2012).  Participants fasted for 12 hours and abstained 
from exercise for 48 hours prior to testing.  In a simulated classroom setting, inspired and expired 
gases were measured for 45 minutes while the participants performed activities such as word 
finds and crossword puzzles.  Kilocalorie (kcal) expenditure per minute significantly increased 
from sitting to standing (p≤.0001; Reiff et al., 2012).  The generalizability of the results is limited 
to young, healthy adults.  However, a strength of the study was that caloric expenditure was 
measured objectively.  This study provides physiological evidence that standing while performing 
desk work increases energy expenditure.   
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 In contrast, a pilot study examining standing versus sitting or sitting on an exercise ball 
was conducted in a work setting.  The study aimed to test the hypothesis that standing would 
increase daily energy expenditure by 384 kcals (Speck & Schmitz, 2011).  Oxygen consumption 
was measured while sitting on a chair, sitting on an exercise ball, and standing while working on 
a computer for seven minutes.  No significant differences were found in energy expenditure for 
the different working positions.  Limitations of the study include the short duration of 
measurement and failure to examine the effects of intermittent activity during the workday.  
Additionally, the purpose of the pilot study was test whether standing would meet the 
requirements for the recommended daily physical activity (300 kcal/day).  The epidemiological 
evidence demonstrates an increase in all-cause mortality from excessive sitting and prolonged 
sedentary time (Dunstan, Howard, Healy, & Owen, 2012).  The evidence does not; however, 
suggest that standing while working could or should replace daily physical activity.  Further 
experimental studies are needed to determine an appropriate dose and the long-term effect of 
reducing sedentary behavior at work.  
Another study was conducted by Duvivier and colleagues (2013) examining the effect of 
increased walking and standing compared to sitting with a short period of moderate to vigorous 
exercise in healthy adults.  The previously sedentary participants (n=18) were randomized to one 
of the following three different activity programs each lasting four days:  (1) Sitting for 14 hours 
per day; (2) sitting for 13 hours and substituting one hour of sitting for one hour of vigorous 
intensity exercise; and (3) substituted six hours of sitting with four hours of minimal physical 
activity (walking) and two hours of standing (Duvivier et al., 2013).  Physical activity was 
assessed with the activPAL continuously and a physical activity diary.  The number of hours 
spent sitting were comparable between the sitting and vigorous exercise groups and energy 
expenditure was matched between the exercise and minimal intensity groups.   
  21 
The minimal intensity group stood approximately two hours more and performed non-
exercise activity (walking around) almost four hours more than the sitting and exercise groups (p 
< .001; Duvivier et al., 2013). The exercise and minimal intensity groups expended 500 more 
calories daily (p<.001) compared to the sitting group.  Additionally, the insulin area under the 
curve during an oral glucose tolerance test was significantly smaller for the minimal intensity 
group relative to the sitting (p=.010) and exercise (p=.002) groups (Duvivier et al., 2013).  
However, glucose and C-peptide levels were not significantly different during the oral glucose 
tolerance test.  Therefore, one hour of vigorous exercise does not compensate for the negative 
effects of excessive sitting.  
Another study examined the effect of breaking up prolonged sitting on postprandial 
glucose (Peddie et al., 2013).  The study was a randomized crossover trial of apparently healthy 
adults with normal weight (n=70).  The participants were randomized to one of six possible 
orders consisting of the following three; (1) Prolonged sitting (nine hours), (2) walking for 30 
minutes and then sitting, and (3) 1 minute 40 second breaks every 30 minutes.  Standardized, 
weight-based meal replacements were consumed at 60, 240, and 420 minutes (Peddie et al., 
2013).  The activity break intervention resulted in significant reductions in insulin incremental 
area under the curve (iAUC; p<0.001) and significantly lower plasma glucose iAUC (p<0.001; 
Peddie et al., 2013) than the other two conditions. 
The study provides further evidence of the beneficial effect of breaking up prolonged 
sitting.  Regular activity breaks resulted in reduced postprandial glucose and insulin levels.  The 
findings are important for recommending the reduction of prolonged sedentary time among all 
adults.  Additionally, regular activity breaks were more beneficial than one sustained bout of 
physical activity, which is consistent with the previously reviewed literature. The study was 
however conducted in a laboratory setting and among healthy, normal weight adults.  A 
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consistent gap in the literature is the absence of studies examining the effect of breaking up 
prolonged sitting in adults with abnormal glucose regulation. 
Acute bouts of light or moderate intensity activity consistently result in beneficial glucose 
and insulin responses.  The effect of standing breaks has not been widely researched.  In a 
crossover study of non-obese, healthy adults (n=10), three conditions were completed: (1) 
Uninterrupted sitting; (2) 2-min standing breaks every 20 minutes; and (3) 2-min light-intensity 
walking breaks every 20 minutes (Bailey & Locke, 2014 in press).  Consistent with previous data, 
the light-intensity walking breaks reduced postprandial glucose; however, standing breaks did not 
significantly reduce postprandial glucose.  Conducting the study in a laboratory setting is a 
limitation; however, this limitation is somewhat attenuated given the novelty of the research 
topic.  While the study isolated the effect of standing, the participants were instructed to stand 
completely still during the 2-min standing break.  This behavior is not consistent with the real-
world work setting (people do not stand completely still naturally).  Current research is 
continuing to examine the effect of increased standing at work and the subsequent increased 
movement (or light-intensity activity) around the office space once individuals are standing. 
In summary, the experimental literature contains primarily acute studies and studies 
lasting longer in duration are needed.  The prolonged and sustained effect of standing on glucose 
is unknown.  Additionally, the sedentary literature has studied apparently healthy adults and 
therefore, further examination of individuals at risk for chronic disease is needed. 
Part 3: Continuous Glucose Monitoring 
2.7 CGM Technology 
 Continuous glucose monitoring (CGM) technology has been studied primarily in type I 
and type II diabetic populations.  Continuous glucose monitors measure interstitial blood glucose 
using an electrochemical system.  The devices can be worn for up to seven days.  The market is 
currently dominated by three major manufacturers – Medtronic (Medtronic, USA), DexCom 
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(Dexcom, San Diego, CA), and Abbott (Abbott, United Kingdom).  The devices function in a 
blinded fashion or with real-time feedback.  The primary goal of CGM technology is to reduce 
glycemic variability.  Glycemic variability was shown to be associated with increased 
microvascular complications associated with diabetes.  Specifically, results from the Diabetes 
Control and Complications Trial (DCCT) demonstrated increased microvascular complications 
with variable glycated hemoglobin (HbA1c) in a conventional glycemic control group compared 
to an intensive control group (Kilpatrick, Rigby, & Atkin, 2008).  Therefore, through the use of 
CGM technology, glycemic variability and hypoglycemic events (in type 1 diabetics) can be 
reduced which in turn reduces vascular risk (Liebl et al., 2013). 
Currently, the literature does not contain data on the use of CGM in pre-diabetic adults; 
however, the technology has been studied in apparently healthy individuals.  Beck and colleagues 
(2010) conducted a study to evaluate glucose patterns in apparently healthy adolescents and 
adults.  The participants wore the CGM for 3-7 days and, by the nature of the device, were 
blinded to the results.  The study group found that the majority of glucose concentrations (91%) 
were between 71-120 mg/dl, which suggests normal blood sugar regulation in these apparently 
healthy participants.  This study provides baseline data confirming normal function of the device 
in a population free of disease.   
 More recently, CGM was used to examine responses to sitting and standing in apparently 
healthy, desk-based office workers (Buckley, Mellor, Morris, & Joseph, 2014).  The study was an 
open, repeated-measures design performed in a real-world office setting.  Participants (n=2 male, 
n=8 female) wore a CGM, an accelerometer, and a heart rate monitor.  The study was conducted 
over two days.  The participants were fed a standardized lunch prior to the first afternoon of data 
collection.  Following the meal, they proceeded to work as usual in the seated position.  Sit-stand 
desks were installed (Ergotron WorkFit-D, Minnesota, USA).  The next day a standardized meal 
was consumed for lunch but then the participants worked in the standing position for the 
  24 
afternoon.  The CGM was removed on the third day.  Cycle ergometry, measurement of expired 
gases, and heart rate were performed on two days after the study.  The measurements were used 
to calculate energy expenditure. 
 The study resulted in a 43% reduction in postprandial glucose area under the curve in the 
standing condition compared to sitting (p=0.022; Buckley et al., 2014).  Additionally, mean blood 
glucose continued to rise for 85 minutes prior to reaching the peak whereas the standing condition 
peaked at 50 minutes.  Standing work peaked earlier and at a lower mean blood glucose (1.8 
mmol/l vs. 3.1 mmol/l; Buckley et al., 2014).  Finally, mean energy expenditure for the afternoon 
of work was 174±66 kcals greater in the standing compared to the seated work (p=0.028; Buckley 
et al., 2014).   
 Overall, the standing work resulted in a reduced glucose response to the standardized 
meal.  The reduction in the area under the curve corresponded to lower glucose levels while 
standing and to lower peak glucose.  While confirmed previously within the NEAT literature, this 
study confirms increased energy expenditure while performing work standing compared to 
sitting.  The study did, however, contain limitations.  Specifically, it lacked randomization and 
the meals consumed the evening and morning before testing were not controlled.  One strength of 
the study is that it included a standardized meal.  The results provide encouraging evidence for 
the usefulness of acutely reducing postprandial blood glucose responses.  Further long-term 
research is needed among individuals at risk for or with abnormal blood glucose metabolism. 
2.8 Summary and Conclusions 
 Traditional physical activity interventions produce beneficial outcomes for glucose 
regulation and diabetes management (Andrews et al, 2011; The Look AHEAD Research Group, 
2010; ACTID).  These interventions also significantly increase physical activity levels, which 
contributes to health improvements in diabetics.  In addition to traditional physical activity 
prescriptions, the literature suggests that reducing sedentary time and increasing NEAT may be 
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an additional strategy for improving blood sugar regulation and producing beneficial changes in 
weight (Levine & Miller, 2006; Healy et al., 2008).  The detrimental effects of sitting occur 
independent of physical activity level (van der Ploeg, Chey, Korda, Banks, & Bauman, 2012).  
Therefore, interventions are needed to address sedentary time in all individuals regardless of 
physical activity level.  Additionally, an at-risk group, such as those with prediabetes, warrant 
further investigation in order to provide strategies that prevents the progression to type 2 diabetes.  
There is a lack of studies examining the effect of short-term interventions on reducing sedentary 
time in pre-diabetics.  The research has demonstrated that reducing sedentary time and 
incorporating frequent breaks can produce beneficial health outcomes such as improved blood 
glucose regulation, reduced CVD risk, and reduced inflammatory biomarkers in healthy adults 
(Owen, Healy, Matthews, & Dunstan, 2010).  Therefore, adults performing desk-based work with 
prediabetes represent a population in need of further research to prevent disease progression and 
improve health. 
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Study Design 
This dissertation includes two separate trials conducted among the same participants.  
The participants for the two trials were recruited concurrently from a larger worksite wellness 
study.  The participants were involved in both the larger study and the sub-studies.  The larger 
study was a randomized controlled trial examining a six-month worksite wellness intervention.  
The study recruited sedentary office workers (n=163) who were randomly assigned to one of four 
groups; 1) the control group (usual behavior at work), 2) standing at work at least 50% of the 
workday, 3) accruing 30 minutes of walking during the workday through multiple brief bouts, or 
4) the combined standing and walking intervention.  
Twenty female participants were recruited from the larger study for the two separate 
trials presented in the three manuscripts of this dissertation.   
1) The first trial performed was the oral glucose tolerance test (OGTT) study.  Within a 
randomized crossover trial, 20 female participants were randomly assigned to one of 
two conditions: (1) sitting for a 2-hour oral glucose tolerance test; or (2) standing for 
a 2-hour oral glucose tolerance test.  The participants served as their own controls 
within the crossover design.   
2) The second trial was the continuous glucose monitor (CGM) trial.  This study was a 
repeated measures pilot study in which 10 of the initial 20 participants completed two 
study conditions: (1) First, sitting at their desk for one work week while wearing a 
continuous glucose monitor and an accelerometer; and (2) Using their sit-stand desk 
for one work week while wearing the CGM and the accelerometer with a goal of 
standing for at least half of their work day.   
The study was approved by the University of Minnesota’s Institutional Review Board (IRB) and 
was registered as 1208M18741 at ClinicalTrials.gov. 
Participants and Inclusion/Exclusion Criteria 
  28 
 Twenty-seven female participants were recruited from two companies in the Midwest. 
Participants with a fasting blood glucose greater than 100 mg/dl were recruited concurrently from 
a larger study being conducted in the same workplaces.  Participants were recruited from 
informational sessions that were provided to prospective participants for both the current study 
and the larger trial.  Additionally, participants whose blood sugar was greater than 100 mg/dl 
were recruited during the baseline data collection for the current study.  Inclusion criteria were a 
fasting blood sugar greater than 100 mg/dl, ages 18-65 years, and, if taking any, on stable 
medications during the past six months.  Participants were required to work full-time (at least 35 
hours per week) and spend at least 75% of their workday sitting.  Participants were required to be 
able to safely begin a physical activity regimen that primarily involved increased standing, 
walking, and using the stairs. Exclusion criteria were prior history of manifest heart disease, renal 
disease with a creatinine >1.5 mg/dl, peripheral neuropathy, retinopathy, peripheral artery disease 
(PAD), lower limb amputation, pregnancy, active substance abuse, hospitalized in the past six 
months for psychiatric disorder, severe visual impairment, enrollment in a physical activity study, 
and the use of insulin or an insulin pump. 
Measures 
Study measures included sedentary time, physical activity, blood glucose, oral glucose 
tolerance testing (OGTT), continuous glucose monitoring (iPro2®, Medtronic, USA), blood 
pressure, weight, body fat percent, sitting time, and 24-hour dietary records.   
Sedentary time 
Sedentary time and physical activity were measured objectively with the Kinetic Activity 
Monitor (KAM®; Kersh Health, Plano, TX).  The KAM is an accelerometer that measures 
activity intensity and duration.  The KAM was worn on the waistband in line with the knee and 
measured activity counts at low, moderate, and vigorous intensities.  The intensity zones are life 
(<2 mph), health (>2-4.5 mph), and sport (>4.5mph).  The KAM accelerometer was worn during 
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each oral glucose tolerance test and for two weeks while the CGM was worn.  Two OGTT’s were 
performed with the KAM worn at the start of the 2hr test and removed upon completion.  The 
KAM was worn again for two one-week periods while the CGM was worn.  Participants self-
reported daily standing time by recording the total daily amount of standing in their diary for each 
day while wearing the CGM.   
Physiological Measures 
Blood glucose was measured with a glucometer, glucose strip, and lancet (Bayer Breeze 
2, Whippany, NJ).  Oral glucose tolerance testing (OGTT) was conducted two times; once 
standing and once sitting. A 75g glucose load beverage was consumed and blood glucose was 
measured with a glucometer at 30 minute intervals up to 120 minutes (Trutol, ThermoScientific 
Inc., USA).  
During the second trial, the continuous glucose monitor was worn (CGM).  The CGM 
included the sensor that was inserted in the interstitial fluid and the transmitting device that was 
attached to the sensor on the outside of the skin.  The iPro2® by Medtronic is a blinded device 
that uses an electrochemical system.  The sensor is contains three electrodes; (1) reference, (2) 
working, and (3) counter electrodes that complete a circuit (Medtronic, Northridge, CA).  
Additionally, the sensor has three layers.  The outermost layer is a semi-permeable layer that is 
selectively permeable to glucose and oxygen.  The second layer is an enzyme layer, coated with 
glucose oxidase, where the chemical reaction occurs producing hydrogen peroxide and gluconic 
acid.  The gluconic acid is reabsorbed into the body while the hydrogen peroxide travels from the 
enzyme layer to the electrode layer. A small nano-amp runs through the electrode layer.  A 
second chemical reaction occurs when the hydrogen peroxide comes in contact with the nano-
amp.  The hydrogen peroxide is broken down into hydrogen, oxygen, and two electrons.  The 
sensor measures the two electrons and sends the electron current, the ISIG, to the transmitter.  
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Upon download of the transmitter, the ISIG values were converted to glucose values for every 
five minutes the monitor was worn. 
Height and weight were measured using a calibrated scale and stadiometer (Seca; Chino, 
CA).  Body mass index (BMI) was calculated by dividing weight (kg) by height squared (m
2
).  
Body fat percent was obtained by dual energy x-ray absorptiometry (DXA).  Resting blood 
pressure was measured with an automatic sphygmomanometer (BPTru, BPM-100; BPM Medical 
Devices).  Cholesterol was measured in a fasted state (Alere Cholestech LDX).  The fasted state 
was considered the absence of food and caloric beverage intake for eight or more hours and was 
verified by self-report. 
Procedure 
 Participants were recruited from two office buildings in the Twin Cities metro area.  
Flyers were posted and emails were sent to employees at one worksite while an advertisement 
was placed on the electronic company newsletter of the other.  Interested participants sent an 
email using the study email address.  Potential participants were screened for eligibility via an 
electronic survey, which included a standard set of questions to determine if they met the 
inclusion and/or exclusion criteria.  Following determination of eligibility, participant consent 
was obtained.  Participants were instructed to fast for eight hours prior to the baseline data 
collection.  Baseline blood sugar was determined prior to randomization to verify eligibility.  The 
finger was prepped with an alcohol swab, lanced, and the initial drop of blood was wiped away.  
A drop of blood was then placed on the glucose strip for the glucometer to analyze (Bayer Breeze 
2; Whippany, NJ).   
Blood pressure was measured with an automatic sphygmomanometer (BPTru, BPM-100; 
BPM Medical Devices).  Participants sat quietly for five minutes prior to the readings and the 
same arm was measured for all readings.  The blood pressure was measured six times. The 
average of those six readings was recorded as the baseline blood pressure.  Height was measured 
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using a stadiometer and weight was measured using a digital scale (Seca; Chino, CA).  
Cholesterol was measured by a finger stick using the Cholestech LDX system.  The finger was 
cleaned with an alcohol swab, lanced, and the initial drop of blood was wiped away.  The 
capillary tube was then filled with blood, which was transferred to the test cassette.  Body fat 
percentage was obtained via DXA.  Participants fasted for at least three hours prior to testing and 
removed shoes, excess outer clothing, metal jewelry, and/or belts.  The participant then laid flat 
on the DXA table with their arms at their sides.  The entire body was scanned lasting 
approximately five minutes.   
Participants were then randomly assigned to sit or stand for the OGTT test utilizing 
simple randomization and computer-generated random numbers.  Using the random numbers 
generated (0=sit, 1=stand), the participant’s assigned zero sat for the first test and those who 
received one, stood for the first test.   
Sit-stand desks were installed at one of the workplaces.  The other workplace already had 
sit-stand desks and they were instructed how to use the desk with proper ergonomics.  
Participants received an ergonomic evaluation, instructions, and an informational website relating 
to the sit-stand desk.  If assigned to sit for the first test, the participants were instructed to remain 
seated at their desk for the entire two hour test and to avoid any activity that would require 
leaving their desk or walking around.  The OGTT was performed in the morning after fasting for 
at least eight hours.  Abstinence from physical activity in the previous 48 hours was required and 
verified.  Baseline blood glucose was measured followed by consumption of a 75g glucose 
beverage (Trutol, Thermo Fisher Scientific, Inc.).  The beverage had to be consumed within five 
minutes.  Blood glucose was measured over the 2h period at 30, 60, 90, and 120 minutes.  The 
participant continued to work as usual during the test.  The researcher reported to the participant’s 
desk every 30 minutes to obtain the blood sample.  Symptoms in response to ingestion of the 
glucose load, if any, were recorded by the researcher.   
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The KAM accelerometer was placed on the participant at the start of the test and worn on 
the front of the pants, in line with the knee.  The KAM was collected at the end of the test.  
Testing was not performed on consecutive days.  A minimum of one day was placed between 
each test.  For the standing OGTT, participants were instructed to stand at their desk for the entire 
two hour period.  They were again instructed to remain at their desk for the entire two hour 
period.  The same blood glucose measuring and beverage consumption procedures were 
completed for the standing test.  Following completion of both oral glucose tolerance tests, the 
participant was scheduled for the first week of continuous glucose monitoring (CGM). 
The second trial, wearing the continuous glucose monitor (CGM), was completed once 
both OGTT tests were finished.  During the first week, the participants continued to work in the 
seated position.  The KAM was given to the participant on the first day of the week and worn 
during waking hours until the CGM was removed.  The CGM sensor was inserted on the first day 
of the week.  The sensor was placed in a position that would not interfere with the participant’s 
daily life, which was generally on either side of the low back or the upper portion of the gluteus 
maximus.  A site that was primarily fat tissue and free of stretch marks, scarring, or hardened 
tissue beneath the skin was chosen.  The sensor was inserted using an insertion device.  The 
sensor was allowed to “wet” for at least 15 minutes under the skin.  The iPro2® was then 
attached to the sensor and taped down securely with transparent film dressings (3M Tegaderm®).  
The participant was told the requirements while wearing the CGM.   
The participant was required to measure their blood glucose while wearing the iPro2®.  
A calibration blood sugar was required at least four times per day (before breakfast, lunch, dinner, 
and before going to bed) but absolutely had to be measured every 12 hours.  They were supplied 
with daily diaries for recording blood glucose readings, dietary intake, and physical activity.  
Meals, beverages, snacks, and the amount of each consumed was recorded daily.  Amount and 
type of physical activity, if any, was recorded daily.  While wearing the device, the participant 
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was able to shower and perform all other activities as usual.  They were told to refrain from using 
a hot tub as the sensor and iPro2® could not be guaranteed to function in that setting.  The sensor 
and iPro2® were removed at the end of the week.  The tape was peeled off and the sensor was 
removed from the skin and discarded in a sharps container.  The iPro2® was cleaned according to 
Medtronic and the Food and Drug Administration (FDA) guidelines.  Once clean, the iPro2® was 
connected to a computer and the data was downloaded.  The daily diaries were collected and the 
calibration blood sugars, meals, and physical activity were entered into the software (CareLink, 
Medtronic, USA).  The software used the calibration blood sugars to produce blood glucose 
readings from the sensor measurements.  A blood glucose reading was computed in five minute 
intervals while the sensor was worn.  The KAM was collected on the last day of the week and 
downloaded. 
Participants performed an acclimation period of at least three weeks prior to wearing the 
CGM again.  Following the first CGM session, participants were instructed to gradually increase 
their daily standing to achieve a cumulative total of four hours of standing per day.  They were 
not required to stand for four continuous hours but rather to accumulate four hours throughout 
their work day.  They were also instructed to wear appropriate footwear while standing such as 
tennis shoes rather than high heels or dress shoes.  The KAM was worn again for the entire work 
week.  The device was delivered and picked up from the participant at their workplace.  The data 
from the KAM was downloaded to a software program, which resulted in total KAM points and 
minutes spent in life, health, and sport zones.  The same CGM procedures were followed during 
the second week of data collection.  However, daily standing time was recorded in addition to 
blood glucose readings, dietary intake, and physical activity.  Participants were provided with a 
study email to send questions to the researcher as needed and a phone number had any emergent 
issues arisen.  A supervising physician was part of the study team and was available to contact 
with questions and concerns that developed during the study.  One participant was compensated 
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$150.00 for participation in both trials ($10 for the first OGTT, $20 for the second, $40 for the 
first CGM, $80 for the second).  The remainder of the participants were employees of the state of 
Minnesota and could not accept compensation. 
Data Analysis 
 Data were analyzed using SPSS (v21.0) for Windows and Microsoft Excel (2010).  
Participant characteristic data was analyzed in SPSS (v21.0) and Microsoft Excel (Windows 
2010).  Area under the curve (AUC) was calculated for the sitting and standing OGTT data.  For 
each glucose interval, the values were subtracted from baseline.  The trapezoidal area was then 
found for the sitting and standing conditions.  Finally, AUC was calculated in the sitting and 
standing conditions followed by the difference in the two conditions.   
The CGM data were evaluated using a linear mixed model regression analysis for a 
crossover design in SAS (v9.3).  Dietary, physical activity, sedentary time covariates (i.e. 
carbohydrates, protein, fat, and fiber) were controlled for within the model.  The KAM data was 
analyzed in Microsoft Excel (Windows 2010).  The mean difference of minutes spent in the life, 
health, sport, and combined life and health zones was calculated.  Values are reported as mean 
[SD and SE] and 95% CI. 
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Abstract 
 Objective: Sedentary time and physical inactivity are related to deleterious effects on 
cardiometabolic risk markers.  The purpose of this study was to examine the effect of sitting 
versus standing on glucose tolerance during a 2-h oral glucose tolerance test (OGTT) among 
working adults with prediabetes.  Research Design and Methods: This study was a randomized 
cross-over pilot study in which participants performed two 2-hr OGTT’s; one sitting and one 
standing.  The study was conducted under free living conditions at the participant’s workplace.  
Participants were female volunteers (n=14) recruited from two Midwest-based companies.  On 
average, participants were 49 years of age and obese (mean BMI was 31.2).  Inclusion criteria 
included a fasting blood sugar >100 mg/dl (m = 108 ± 5.2 mg/dl), full-time employment 
(working at least 35 hours per week), a sedentary job (sitting for 75% of the work day), stable 
medications for 6 months among individuals taking medications, able to safely participate in low-
moderate physical activity, and 18-65 years of age. Results: Results indicated an increased 
postprandial glucose response in the standing group (Glucose iAUC = -124.9 ± 481.7, 95% CI [-
386.7, 137]) relative to the sitting group.  Conclusions:  The data suggest that continuous 
standing following consumption of a glucose load is detrimental.  Future research is needed with 
larger sample sizes to evaluate the acute and prolonged effects of standing among individuals at 
risk for diabetes.   
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Introduction 
 Diabetes and obesity have reached epidemic levels across the world (Naser, Gruber, & 
Thomson, 2006).  Currently, an estimated 79 million Americans have prediabetes, which puts 
those individuals at risk for type 2 diabetes (CDC, 2011).  Prediabetes is diagnosed by one of 
three tests; (1) a Hgb A1C of 5.7-6.4%; (2) a fasting blood glucose of 100-125 mg/dl; or (3) a 
blood glucose reading of 140-199 mg/dl during an oral glucose tolerance test (American Diabetes 
Association, 2013).  An estimated 70% of individuals with prediabetes are predicted to develop 
type 2 diabetes (Nathan et al., 2007).  Diagnosed diabetes has increased 176% between 1980 and 
2010 (CDC, 2012).  In 2010 alone, 1.9 million adults were diagnosed with diabetes (CDC, 2011).  
Assuming the incidence rate of diabetes diagnoses have remained constant since 2010, the current 
estimate would suggest that 86.6 million Americans have prediabetes.  Therefore, it is important 
to intervene among adults with prediabetes in order to prevent the onset of type 2 diabetes.  
Increasing physical activity and decreasing sedentary time is one potential strategy for improving 
blood sugar regulation problems among individuals with prediabetes.   
Extended periods of sitting and sedentary behavior are prevalent among office-based 
workers (Jans, Proper, & Hildebrandt, 2007).  Individuals who have occupations that involve 
prolonged sedentary time spend approximately 77% of their day engaged in sedentary behavior 
(Thorp et al., 2012).  A majority of workers have sedentary jobs and this number is projected to 
increase through 2022 (Bureau of Labor Statistics, 2012).  Adults spend about one-third of their 
life at their highly sedentary job (Jans et al., 2007).  Studies indicate a strong relationship between 
sedentary behavior and all-cause mortality and cardiovascular disease mortality risk (Hamilton, 
Healy, Dunstan, Zderic, & Owen, 2008; Dunstan, Thorp, & Healy, 2011; Dunstan, Howard, 
Healy, & Owen, 2012).  Epidemiological evidence has also demonstrated an increased risk of all-
cause mortality in individuals with high levels of daily sitting time (van der Ploeg, Chey, Korda, 
Banks, & Bauman, 2012).  Additionally, sedentary behaviors have been associated with 
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metabolic syndrome, adverse insulin and glucose profiles, and type 2 diabetes (Dunstan et al., 
2004; Dunstan et al., 2005; Dunstan et al., 2007; Hu et al., 2001; Thorp et al., 2010).   
Sedentary behavior is defined as activities in either the sitting or reclining position and 
those of very low intensity (MET levels of 1.0-1.5; Owen et al., 2010).  In one study, interrupting 
prolonged sedentary time with frequent breaks was associated with decreased waist 
circumference, body mass index (BMI), triglycerides, and 2-h plasma glucose (Healy et al., 
2008).  The beneficial associations of frequently interrupting sedentary time did not depend on 
the overall amount of sedentary time and moderate-to-vigorous intensity physical activity (Healy 
et al., 2008).   
In another study among overweight and obese adults without diabetes, the acute effect of 
breaking up prolonged sitting was examined (Dunstan et al., 2012).  Specifically, participants 
consumed a standardized test drink and randomly completed three treatments in an acute 
crossover trial; 1) uninterrupted sitting; 2) sitting with two-min bouts of light-intensity walking 
every 20 minutes; and 3) sitting with two-min bouts of moderate-intensity walking every 20 
minutes (Dunstan et al., 2012).  Light and moderate-intensity bouts of walking reduced 
postprandial glucose and insulin relative to uninterrupted sitting (Dunstan et al., 2012). There 
were no differences between the light and moderate intensities on glucose and insulin incremental 
area under the curve (i.e., the area under the blood glucose and insulin response curves following 
ingestion of a standard test drink; Dunstan et al., 2012).  Therefore, light intensity activity was as 
effective as moderate intensity activity in reducing postprandial glucose and insulin.  The 
associations of objectively measured sedentary time and light, moderate, and vigorous-intensity 
physical activity with 2-h OGTT were examined in a sample of Australian adults (Healy et al., 
2007).  Light, moderate, and vigorous-intensity activity were negatively associated with 2-h 
plasma glucose while sedentary time was positively associated (Healy et al., 2007).  Additional 
research indicates that light-intensity physical activity is related to improvements in blood sugar 
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regulation.  Also, sedentary behavior is negatively associated with proper blood glucose 
metabolism, continuous blood glucose measures and the metabolic syndrome (Healy et al., 2008; 
Sugiyama, Healy, Dunstan, Salmon, & Owen, 2008).   
In summary, the epidemiological and observational evidence demonstrate the deleterious 
effect of prolonged sitting.  There are no specific guidelines and recommendations for the proper 
prescription for standing for the general population and individuals with impaired fasting glucose.  
Research is needed to better understand the effect of standing on at-risk adults with impaired 
fasting glucose who work at a sedentary job.  The purpose of this study was to examine the effect 
of sitting vs. standing on glucose responses during a 2-hr OGTT among adult females with 
impaired fasting glucose.  No study has examined the effect of standing while working on 2-hr 
OGTT in adults with impaired fasting glucose.  It was hypothesized that participants would have 
significantly lower glucose responses during a 2-hr OGTT after standing compared to when 
sitting.  
Methods 
Study Design and Participants 
This study was a randomized, cross-over pilot study examining blood sugar measured by 
an oral glucose tolerance test (OGTT) in adults with impaired fasting glucose.  The participants 
served as their own control.  The study was performed under free living conditions at the 
participant’s place of work.  Each participant completed two conditions, which were randomly 
counterbalanced; (1) sitting and (2) standing for the entire two-hour test.  Volunteers (n=27 
females) were recruited from two worksites in the upper Midwest via an advertisement within the 
electronic employee newsletter and flyers posted in the building.  The participants were recruited 
simultaneously with a larger worksite wellness study (n=144 females; n=19 males).  All 
participants in the current study also participated in this larger worksite study (a workplace 
wellness study examining the effect of sit-stand desks on reducing sedentary time relative to a 
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weekly wellness program).  Informational in-person sessions were conducted at the worksites 
where both studies were discussed followed by question and answer sessions.  Interested 
participants contacted the study coordinator via email and were then sent a screening 
questionnaire to determine their eligibility.   
Inclusion criteria included a fasting blood glucose greater than 100 mg/dl, stable 
medications for the last six months, working full-time (at least 35 hours per week) with at least 
75% of the work day spent sitting, and able to safely begin a physical activity regimen that 
primarily involved increased standing, walking, and using the stairs.  Exclusion criteria included 
prior history of manifest heart disease, type 1 or type 2 diabetes, renal disease with a creatinine 
>1.5 mg/dl, peripheral neuropathy, retinopathy, peripheral artery disease (PAD), lower limb 
amputation, pregnancy, active substance abuse, hospitalization in the past six months for 
psychiatric disorder, severe visual impairment, enrollment in a physical activity study, and the use 
of insulin or an insulin pump.  Informed consent was completed by each participant followed by 
the collection of health and medical history.  Data for this study was collected between February-
July 2013.  The study was approved by the University of Minnesota’s Institutional Review Board 
and registered as 1208M18741 at ClinicalTrials.gov. 
Measures 
Anthropometric Measures 
 Height and weight were measured using a calibrated scale and stadiometer (Seca; Chino, 
CA).  Body mass index (BMI) was calculated and body fat percent was obtained by dual energy 
x-ray absorptiometry.  Resting blood pressure was measured following five minutes of sitting 
quietly (BPTru, BPM-100; BPM Medical Devices).  Cholesterol was measured in the fasting state 
(Alere Cholestech LDX) using a finger stick sample.  Finally, fasting glucose was measured at 
baseline to determine eligibility (Bayer Breeze 2; Whippany, NJ).   
Oral Glucose Tolerance Testing (OGTT) 
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The Oral Glucose Tolerance Test (OGTT) was used as the measure of insulin sensitivity 
due to its feasibility to administer and its correlation with hyperinsulinemic euglycemic clamp, 
the gold standard (r=-0.61, p<0.001; Tran et al., 2003).  Oral glucose tolerance testing involves 
blood sugar measurements and the consumption of a glucose or mixed-meal beverage.  A 75g 
glucose beverage was consumed for the OGTT (Trutol, ThermoScientific).  All tests were 
completed in the morning at the start of the work day.   
Physical Activity Monitoring 
Participants wore an accelerometer (Kinetic Activity Monitor [KAM]; Kersh Health, 
Plano, TX) during each test to detect any excessive activity in either condition.  The KAM detects 
low intensity to vigorous-intensity activity.  Therefore, it can detect the low levels of activity 
associated with moving around one’s desk and office space.  The KAM divides activity into three 
intensities; life (<2 mph), health (2-4.5 mph), and sport (>4.5 mph). Each KAM point obtained 
from the monitor corresponded to a 1% increase above basal metabolic rate.  
Procedures 
Following the informational sessions, interested participants contacted the study email 
and an eligibility questionnaire was sent by the study coordinator via SurveyMonkey.  Informed 
consent was obtained prior to baseline anthropometric data collection.  Fasting blood glucose, 
cholesterol, height, weight, blood pressure, and body fat percentage were measured at baseline.  
Individuals with a FBG > 100 mg/dl were eligible for the present study.  The testing was 
scheduled on two separate mornings at the participant’s workplace.  Following baseline data 
collection, OGTT testing was scheduled.  Tests were performed at the participant’s desk and 
therefore, all participants were scheduled individually for each test.  One 2-h OGTT was 
performed sitting and one performed standing in random order.  Testing was not performed back 
to back; however, the number of days between testing was different between participants based 
on their availability and work schedule (i.e. days between tests ranged from 1-22 days).  
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Participants were instructed to eat the same meal the night before each test, refrain from intense 
physical activity for 48 hours before the test, and to fast for eight hours before the tests.  Prior to 
each test, the researcher recorded dietary intake from the previous evening, verified the 
participant was in the fasting state, and had abstained from physical activity within the past 48 
hours.  Participants were instructed to remain at their desk for the entire two-hour test and to 
continue work as usual.  It was suggested that the restroom be used prior to beginning the test to 
avoid movement away from their desk during each test.  They were instructed to avoid any 
additional walking around the office such as picking up papers from a printer.   
A baseline blood sugar was measured prior to consumption of the beverage.  The 
subject’s skin was cleaned and prepped using sterile techniques.  The finger was then lanced and 
the initial drop of blood was wiped away.  The sample was then applied to the glucose test strip 
for measurement by the glucometer (Bayer Breeze 2; Whippany, NJ).  A 75g glucose beverage 
(Trutol, ThermoScientific) was consumed within five minutes.  Blood sugar was measured by 
finger stick again at 30, 60, 90, and 120 minutes following beverage consumption.  Any 
symptoms experienced during the test were recorded for each participant. In the event of a 
questionable blood sugar measurement during the test, another sample was measured to maintain 
reliability of the glucometer.  A sample of participants (n=5) were re-tested because of unreliable 
glucose readings due to a glucometer malfunction.  However, re-testing was stopped following 
analysis of the data due to the suspected adverse effect of standing continuously for two hours.  
Finally, physical activity was monitored with the KAM during each test.  The participant was 
given the KAM at the start of each test and it was removed after the 2-h tests were completed.  
The participant was instructed to wear the KAM on the front of their pants, in line with the knee.  
One participant received compensation for participating in the study ($30).  The other participants 
were unable to accept compensation because they work for the government.    
Statistical Analyses 
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 All data were analyzed using SPSS (v21.0) for Windows and Microsoft Excel (Windows 
2010).  Incremental area under the curve was calculated for the glucose values.  For each glucose 
interval, the values were subtracted from baseline.  The trapezoidal area was then found for the 
sitting and standing conditions.  Finally, area under the curve (AUC) was calculated in the sitting 
and standing conditions followed by the difference in the two conditions.  Values are reported as 
means [SD] and 95% CI in the text and tables. 
Results 
 Twenty seven females enrolled into the study.  Twenty eligible female participants 
completed the study (three withdrew and four were ineligible due to meeting exclusion criteria). 
Ten participants had baseline glucose values that were deemed inaccurate suggesting malfunction 
of the glucometer.  Blood glucose values that differed by greater than 10 mg/dl between the 
baseline sitting and standing measures were excluded.  Therefore, the analysis was conducted on 
the remaining 10 participants.  Participants were recruited between January-February, 2013.  As 
shown in Table 1, the participants were primarily middle aged female adults with BMI levels in 
the overweight and obese ranges and corresponding body fat percentages in the overfat and obese 
ranges.  Fasting glucose was on average 108 mg/dl.  Participants on average had normal blood 
pressure, slightly elevated cholesterol levels, and elevated triglyceride levels.  Three participants 
were taking chronic prescription medications for disorders unrelated to impaired fasting glucose. 
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Table 4-1  
Participant Characteristics (n=10) 
Variables         M (SD)     
Age (years)        50.6    (8.5) 
Height (m)          1.65    (.06) 
Weight (kg)        91.9  (15.6) 
BMI         32.9    (3.9) 
Body fat %
a
        48.7    (4.0) 
SBP       122.3  (11.0) 
DBP         81.9    (7.5) 
Fasting blood glucose (mg/dl)    108.4    (5.6) 
Total cholesterol
a
 (mg/dl)    207.1  (37.6) 
LDL – cholesterola (mg/dl)    121.3 (40.0) 
HDL – cholesterola (mg/dl)      50.8  (14.8) 
Triglycerides (mg/dl)     176.6  (84.1) 
Note.  BMI=Body Mass Index; SBP=Systolic blood pressure; DBP=Diastolic blood pressure; 
LDL=low-density lipoprotein; HDL=high-density lipoprotein. 
a
n=8.   
 
Oral Glucose Tolerance Testing 
 The mean postprandial blood glucose values were 135.4 ± 26.0 mg/dl and 149.4 ± 28.6 
mg/dl for the sitting and standing conditions, respectively.  The mean difference for the glucose 
area under the curve (AUC) was -124.9 ± 481.7, 95% CI [-386.7, 137].  Figure 4-1 shows the 
glucose incremental area under the curve (iAUC) for each study condition.  While the results are 
not statistically significant, a trend toward improved glucose clearance is evident in the standing 
compared to the sitting group.   
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Figure 4-1.  Two-hour postprandial glucose incremental area under the curve (n=10).  
Incremental values were subtracted from baseline.  Mean values are plotted.  
  
Four participants met the diagnostic criteria for impaired glucose tolerance (IGT; BG 
140-199 mg/dl) during the sitting test and six during the standing test.  A total of four participants 
demonstrated IGT in both conditions.  The participants with positive OGTT results had impaired 
fasting glucose (IFG) and IGT; otherwise known as combined glucose intolerance (CGI; Abdul-
Ghani, Tripathy, & DeFronzo, 2006).  Finally, one participant met the diagnostic criteria for 
diabetes during the standing test (BG ≥ 200 mg/dl).  The participant was given the results of both 
tests and instructed to follow-up with her primary care doctor regarding the results.    
 
Discussion 
This study is the first study, to our knowledge, to examine the effect of standing on 
postprandial glucose during a 2-h OGTT in adults with impaired fasting glucose (IFG) in free-
living conditions.  The results provide preliminary evidence for the effect of standing while 
working on postprandial glucose in adults with impaired fasting glucose.  All participants met the 
criteria for impaired fasting glucose (IFG) at baseline (FBG 100-125 mg/dl).  In addition to IFG 
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at baseline, participants then met impaired glucose tolerance (IGT) diagnostic criteria (140-199 
mg/dl) and diabetes diagnostic criteria (>200 mg/dl).  Considering all participants had IFG at 
baseline, the participants who additionally demonstrated IGT and diabetes possess underlying 
metabolic differences in blood glucose regulation compared to those with IFG alone.  
Explanations for the differing responses to the glucose load include changes in diagnostic criteria, 
a stress response, metabolic differences between IFG and IGT, inaccurate glucose readings, and a 
small sample size.   
The change in IFG diagnostic criteria now identifies individuals early in the blood 
glucose regulation disease process.  In 2003, the threshold for prediabetes and diabetes diagnoses 
was lowered from 110 mg/dl to 100 mg/dl and 140 mg/dl to 126 mg/dl, respectively. (Follow-up 
Report on the Diagnosis of Diabetes Mellitus, 2003).  This change has resulted in the increased 
identification of early glucose regulation abnormalities.  Therefore, the current study included 
participants with varying degrees of blood glucose regulation abnormalities.  Increasing the 
inclusion threshold to 110 mg/dl may have attenuated this problem.  In addition to changes in the 
diagnostic criteria, differences exist metabolically between individuals with IFG alone, IGT 
alone, or the combination of IFG and IGT.   
While both IFG and IGT are insulin-resistant states, the site of insulin resistance is 
different (Abdul-Ghani et al., 2006).  Therefore, the pathophysiology of progression to type 2 
diabetes is different.  Individuals with IFG primarily have hepatic insulin resistance with normal 
muscle insulin sensitivity (Abdul-Ghani et al., 2006).  In contrast, hepatic insulin is slightly 
reduced and severe muscle insulin resistance occurs with IGT (Abdul-Ghani et al, 2006).  
Reducing sedentary time will likely benefit these individuals; however, the duration and amount 
is unknown.  Little research exists specifically examining the effect of standing, separate from 
low-moderate intensity activity, on postprandial blood glucose, especially in adults with 
prediabetes.  In a recent laboratory-based study of healthy adults, sitting with light intensity 
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activity breaks (two minutes) during a 5-h test period significantly reduced postprandial glucose 
and insulin compared to uninterrupted sitting.  In contrary, sitting with standing breaks (two 
minutes) did not (Bailey & Locke, 2014 in press).  Standing breaks did not significantly reduce 
postprandial glucose in healthy adults; however, the duration of standing may not have been 
sufficient.   
A precise dose of standing while working is unknown; however, the current 
recommendation for apparently healthy adults is to avoid prolonged sitting by getting up 
approximately every 20 minutes (Dunstan et al., 2012).  In the current study, an initial 2-h bout of 
standing (rather than intermittent standing) in a naïve population may have produced a stress 
response that could have attenuated the glucose response.  Specifically, the stress response 
impairs insulin sensitivity and would therefore explain, in part, the higher responses in the 
standing condition.  This could have been caused by other factors as well (i.e., Adverse symptoms 
from the glucose beverage, musculoskeletal discomfort from standing, and anxiety over multiple 
blood sugar measurements).  Six participants reported adverse symptoms following consumption 
of the beverage while standing compared to only two while sitting.  Therefore, standing for an 
extended duration may have produced a stress response that affected blood sugar and produced 
outward symptoms.  However, these differences were not statistically significant in this small 
sample so additional research is needed.     
Limitations of the study include the sample size, eligibility criteria (FBG > 100 mg/dl), 
and the study protocol.  The sample size was small; however the study was conducted as a pilot 
study to provide baseline findings to inform future research.  Increasing the eligibility criteria for 
FBG to 110 mg/dl would have led to a sample with comparable metabolic abnormalities (i.e. all 
subjects would demonstrate true and consistent impaired fasting glucose).  The study protocol 
required a continuous bout of standing whereas the appropriate protocol would have alternated 
sitting and standing bouts.  A revised protocol would aim to eliminate the stress response to the 
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continuous bout of standing.  Additionally, the participants were not monitored continuously so it 
is unknown how often the participant went from a sitting to standing position during the seated 
test.  The inaccurate readings related to glucometer malfunction were an additional limitation.  
The fasted state was verified by self-report and is another limitation that may have impacted the 
inaccurate glucose readings.  Duplicate measuring in future studies will reduce measurement 
error.  Additionally, the present study was comprised of female volunteers and therefore, the 
generalizability of the outcomes is limited to females.  Finally, the pre-test diet was not 
controlled, which may have influenced the glucose response between and within persons.    
Considering the current obesity and diabetes epidemics, additional research is needed to 
further examine the effect of low-level activity in the workplace, especially among individuals 
with blood glucose metabolism abnormalities.  A follow-up study based on the lessons learned 
from the current study would include a revised protocol and would consider administering a 
mixed-meal beverage rather than the glucose load.  A protocol with alternating sitting and 
standing bouts would increase the use of the large muscles in the legs and hypothetically lead to 
increased glucose clearance.  The mixed-meal beverage may lead to a reduction in symptoms 
compared to the 75g glucose load.  Consequently, a follow-up to the current study with an 
improved protocol will be equipped to examine the effect of increased activity on postprandial 
glucose in adults with impaired fasting glucose.  
Additionally, a group of participants demonstrated combined glucose intolerance (CGI; 
IFG and IGT).  Individuals with CGI represent approximately 15-20% of those with glucose 
intolerance and they have double the risk of developing type 2 diabetes (Unwin, Shaw, Zimmet, 
& Alberti, 2002).  The increased risk is due to the severity of the combined hepatic and muscle 
insulin resistance.  Therefore, this group warrants attention and further research on how activity 
in the workplace can reduce the risk of disease progression.  Furthermore, males should be 
recruited in future studies to identify the effects of standing in males and to allow generalizability 
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of the results to both genders.  Finally, the long-term effect of intermittent standing in the 
workplace on blood glucose control should be examined in this population.   
Intermittent standing while working has the potential to produce beneficial responses in 
postprandial glucose in female adults with prediabetes.  A prolonged bout of standing following 
glucose ingestion; however, is not recommended.  Further research will increase the knowledge 
base of the response to low-level activity such as standing in the workplace among those with 
IFG and IGT.  This knowledge will inform the development of specific recommendations for 
standing while working in this population.   
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The Short-term Effect of Sit-Stand Workstations on Blood 
Glucose in Women with Impaired Fasting Glucose While 
Working 
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Abstract 
Objective:  The purpose of this study was to examine the effect of using a sit-stand desk while 
working on blood glucose control (monitored continuously) among women with impaired fasting 
glucose.  Research Design and Methods:  The study was a repeated measures pilot study.  
Participants (n=10) were overweight or obese adult females with impaired fasting glucose (blood 
glucose >100 mg/dl) who performed a sedentary job.  Participants were recruited from two upper 
Midwest office buildings. Blood glucose was monitored with continuous glucose monitoring 
technology (CGM) during two, one-week periods at work.  Participants first completed a pre-test 
for one week in the traditional seated position while working.  The second week participants were 
instructed to alternate bouts of sitting and standing (by adjusting their desk) with the goal of 
standing for half of the workday.  Results:  The sit-stand condition resulted in reduced blood 
glucose levels relative to the sitting condition; however, this trend was not significant.  
Carbohydrates, protein, and fat, significantly predicted blood glucose (p<.0001).  Specifically, 
carbohydrate and protein consumption increased blood glucose while fat reduced blood glucose.  
Sedentary time also significantly predicted blood glucose independent of overall physical activity 
(p = .015).  Conclusions:  Our findings suggest that there is no effect of standing on blood 
glucose levels in pre-diabetic women.  Sedentary time is however a strong predictor of increased 
blood glucose.  Future research with larger sample sizes and longer intervention periods are 
needed to further examine the effect of reducing sedentary time in the workplace on blood 
glucose among individuals with impaired fasting glucose.  
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Introduction 
Sedentary behavior is a distinct cardiometabolic risk factor that has been shown to occur 
independently of habitual physical activity (Wilmot et al., 2012, Saunders et al., 2012).  More 
specifically, prolonged bouts of sedentary time are associated with adverse health outcomes 
including type 2 diabetes and premature mortality (Dunstan, Howard, Healy, & Owen, 2012).  
Additionally, sedentary behavior is inversely associated with insulin action (Dunstan et al., 2007; 
Healy et al., 2007; Healy et al., 2008).  Breaking up prolonged sedentary time is associated with 
beneficial effects on cardiometablic risk markers such as reducing BMI, waist circumference, 
triglycerides, and postprandial glucose, regardless of both total sedentary time and moderate-
vigorous intensity activity (Healy et al., 2008).  Laboratory-based studies have demonstrated 
reductions in postprandial glucose and insulin concentrations following short activity breaks (e.g., 
low intensity walking; Dunstan et al., 2012, Peddie et al., 2013). 
Working adults spend approximately one-third of their lives at work and 77% of this time 
is spent engaged in sedentary behavior (Jans, Proper, & Hildebrandt, 2007; Thorp et al., 2012).  
Recent studies have demonstrated the feasibility of replacing traditional desks with height-
adjustable workspaces to reduce sedentary time (Alkhajah et al., 2012; Healy et al., 2013).  These 
height-adjustable workspaces could have important implications for decreasing sedentary time 
and improving cardiometabolic risk factors such as impaired fasting glucose.   
Impaired fasting glucose (IFG) affects an estimated 79 million Americans over the age of 
20 (Centers for Disease Control and Prevention [CDC], 2011).  Impaired fasting glucose 
increases an individual’s risk of developing type 2 diabetes, cardiovascular disease, and stroke 
(CDC, 2011).  Weight reduction and increased physical activity are effective strategies for 
preventing or delaying the onset of type 2 diabetes (CDC, 2011).  Additionally, research indicates 
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that reducing sedentary time is an effective strategy for reducing the risk of type 2 diabetes 
(Dunstan et al., 2012; Peddie et al., 2013). A limitation of these studies is that they did not did not 
continuously monitor glucose levels. Continuous glucose monitoring technology generates 288 
(every five minutes) glucose measures in a single day (Medtronic, Northridge, CA).  Therefore, 
this technology enables near continuous examination of glycemic variability, which can be 
tracked for up to seven days. 
Continuous glucose monitoring (CGM) technology was developed in response to the 
need for improved glucose control to reduce complications related to diabetes and to decrease the 
risk of severe hypoglycemic episodes (Stratton et al., 2000; Kim et al., 2012).  Prior to CGM, 
HbA1c was the primary measurement tool for assessing glucose variability. One problem was 
that treatment responses to HbA1c levels were leading to episodes of severe hypoglycemia, 
primarily in individuals with type 1 diabetes. Because HbA1c reflects the average control of 
blood glucose, methods capable of frequently monitoring blood glucose control were needed.  
Additionally, diabetes-related complications were occurring inconsistently in patients with the 
same HbA1c levels (Hirsch & Brownlee, 2005).  Clinically, CGM is currently recommended for 
managing type 1 diabetes and now functions simultaneously with insulin pumps to form an 
artificial pancreas (Medtronic, Northridge, CA).  Clinical recommendations state that individuals 
with type 2 diabetics who have difficulty controlling hypoglycemic episodes should use CGM but 
in general CGM is not used daily (Kim et al., 2012).   To date, CGM technology has not been 
studied in adults with IFG.  In addition, the effect of intermittent standing on glucose control in 
adults with IFG over an entire work week has yet to be examined.  The observational and lab-
based studies have examined healthy, overweight, and obese individuals and therefore, 
investigating the effect of a sit-stand workstation on blood glucose among individuals with 
impaired fasting glucose would address a gap in the literature.   
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The purpose of the current study was to examine the effect of intermittent standing during 
the workday on blood glucose levels among women with IFG.  Specifically, women with IFG 
participated in a one week traditional sitting pre-test followed by a one-week sit-stand 
intervention both conducted at their workplace.  The effect on the sit-stand intervention on 
continuously monitored glucose (specifically focusing on working hours) was examined.  We 
hypothesized that blood glucose would be lower during the sit-stand intervention than during the 
pre-test.  This study is the first to our knowledge to examine continuous blood glucose responses 
to intermittent standing while working among women with impaired fasting glucose.  
Methods 
Study Design and Participants  
This study was a repeated measures pilot study examining the effect of sitting vs. 
standing on blood glucose responses based on continuous glucose monitoring (CGM) technology.  
Participants wore a Continuous Glucose Monitor (CGM) on two separate occasions: (1) one work 
week while using a desk in the traditional seated position (pre-test), and (2) a second work week 
while standing for half of the workday.  Participants (n=10) were recruited from two workplaces 
in the upper Midwest.  Recruitment methods included flyers, advertisements on the electronic 
company newsletter, and informational sessions at the worksites.  The volunteers in the present 
study were recruited from and concurrently enrolled in a larger worksite wellness study (a 
worksite wellness study examining the effect of sit-stand desks, walking, and wellness education 
on reducing sedentary time in the workplace).  The studies began at the same time.   
Inclusion criteria included impaired fasting glucose (fasting blood glucose greater than 
100 mg/dl), stable medications for the last six months, being a full-time employee (working at 
least 35 hours per week), daily work performed in the seated position (at least 75% of the work 
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day spent sitting), and able to safely participate in physical activity that involved increased 
walking, standing, and using the stairs.  Exclusion criteria included a history of heart disease, 
type1 or type 2 diabetes, renal disease, peripheral neuropathy, retinopathy, peripheral arterial 
disease (PAD), lower limb amputation, pregnancy, active substance abuse, hospitalization in the 
past six months for a psychiatric disorder, severe visual impairment, enrollment in a physical 
activity study, and insulin therapy.  Informed consent was obtained and past medical history was 
collected.  The study is registered as 1208M18741 at ClinicalTrials.gov and was approved by the 
University of Minnesota’s Institutional Review Board. 
Measures 
Anthropometric Measures 
 Baseline data collection included height, weight, blood glucose, cholesterol, blood 
pressure, and body fat percentage.  Measurements were completed in the fasting state in a private 
room at the worksite.  Height and weight were measured with a stadiometer and calibrated scale 
(Seca, Chino, CA).  Fasting blood glucose and cholesterol were measured by a finger stick with a 
glucometer (Bayer Breeze 2; Whippany, NJ) and LDX Cholestech system (Alere Cholestech 
LDX, USA).  Blood pressure was measured with an automatic sphygmomanometer (BPTru, 
BPM-100; BPM Medical Devices).  Finally, body fat percentage was measured with dual-energy 
x-ray apsorptiometry (DXA). 
Continuous Glucose Monitor 
Blood glucose was measured using continuous glucose monitoring (CGM) technology 
(iPro2®, Medtronic, USA).  The iPro2® system consisted of a sensor that was inserted into the 
interstitial fluid and a transmitting device that was attached to the sensor on the outside of the 
skin.  The iPro2® is a blinded device that uses an electrochemical system.  The sensor is made of 
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three electrodes (reference, working and counter electrodes) that complete a circuit.  The sensor 
contains three layers: (1) an outer semi-permeable layer that is selectively permeable to oxygen 
and glucose; (2) a second layer coated with the enzyme glucose oxidase (within this layer a 
chemical reaction occurs producing hydrogen peroxide and gluconic acid); and (3) the innermost 
layer is an electrode layer.  The gluconic acid produced in the second layer is reabsorbed into the 
body.  The hydrogen peroxide from the enzyme layer travels to the electrode layer. The electrode 
layer contains a small nano-amp.  As the hydrogen peroxide comes in contact with the nano-amp, 
a second chemical reaction occurs.  The chemical reaction reduces the hydrogen peroxide into 
hydrogen, oxygen, and two electrons.  The two electrons are measured by the sensor and the 
resulting electron current, the ISIG, is sent to the transmitter.  Upon download of the transmitter, 
the ISIG values are converted to glucose values (in five minute intervals).  The transmitter was 
reusable following proper sterilization and download of the previous data; however, the sensor is 
designed for single use.  The iPro2® could be worn continuously for up to seven days.   
Other Measures  
An accelerometer, the Kinetic Activity Monitor (KAM; Kersh Health, Plano, TX), was 
worn during the trial to measure physical activity.  The KAM measures activity minutes in three 
zones: (1) life (<2mph); (2) health (2-4.5 mph); and (3) sport (>4.5 mph).  The accelerometer 
generates KAM points which correspond to a 1% increase above basal metabolic rate (BMR; 
BMR is calculated within the software using height, weight, age, and gender).  The results from 
the KAM are reported elsewhere (Chapter 6).  Additionally, dietary intake (all meals, snacks, and 
beverages) and physical activity were recorded daily in a diary. 
Procedure  
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 Informational sessions for both studies were conducted at the worksites with question and 
answer sessions following the presentation.  Interested participants contacted the study email and 
an initial eligibility questionnaire was sent in response.  Following informed consent and baseline 
data collection, participants were scheduled for the first week of wearing the CGM.  All 
instructions and expectations were reviewed prior to insertion of the device.  The CGM device 
(i.e., iPro2; Medtronic, USA) was inserted on the first day of the week at the worksite in a private 
room.  To insert the device, a location on the body was chosen that would not interfere with 
normal daily movements, was free of scarring, stretch marks or hardened tissue, and in an area 
that was comprised primarily of fatty tissue.  The device was placed on the side of the low back 
or the top of the gluteus maximus.  The insertion site was sterilized with alcohol and allowed to 
dry.  The sensor was placed in the inserter and the protective coverings removed.  The inserter 
was placed on the skin at a 60° angle.  The sensor was inserted with the insertion device.  The 
inserter was removed from the sensor.  The sensor and the site were monitored for bleeding 
(bleeding was rare, however excessive bleeding could destroy the sensor).  The sensor was 
allowed to “wet” for a minimum of 15 minutes.  During this time the instructions for wearing the 
device were again reviewed. 
 The instructions included educating the participant on how and when to take daily self-
monitored blood glucose (SMBG) measurements.  The SMBG measurements were required for 
calibration of the CGM device.  Participants were instructed to measure their blood glucose 
before breakfast, before lunch, before dinner, and before going to bed every day while wearing 
the device.  The participants were provided with a glucometer, a lancer, and lancets (Bayer 
Breeze 2, Whippany, NJ).  Instructions were given on measurement of blood glucose and the 
participant practiced taking their blood sugar until they were confident in the skill.  The SMBG 
measurements were recorded on the daily diary provided.  Dietary intake including meals, 
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beverages, and snacks were recorded in a diary.  Nutrient composition was derived using the 
USDA National Database for Standard Reference (USDA Agricultural Research Service).  The 
database contains over 8,000 food items.  Quantity and type of food were searched and the 
nutrient composition was recorded for all meals and beverages.  Dietary compositions for meals 
consumed at chain restaurants were cross-checked with the database to ensure accuracy.  Finally, 
daily physical activity was recorded in the diary.  Participants were instructed to continue their 
normal daily activities while wearing the device.  The manufacturer recommended avoiding hot 
tubs or spas given they could cause the device to malfunction.  A phone number and email were 
provided for any emergencies or questions. 
 After 15 minutes of “wetting,” the recording device was attached to the sensor.  The 
recording device displayed a green light signifying the sensor was adequately placed.  After the 
green light was visible, the device was secured with a transparent film dressing (Tegaderm®, 
3M).  The film was hypoallergenic and kept the device in place during most activities.  
Participants were then instructed to record the first SMBG within one hour, a second SMBG three 
hours after insertion, and then on the normal schedule.  A Medtronic specialist was available and 
present for device insertion to address any questions or problems with the equipment. During 
week one of data collection, all participants were instructed to sit at their desk as usual.  At the 
end of the week, the CGM device was removed at the worksite in a private room.  The film was 
removed and the transmitter and sensor were taken out.  The transmitter was removed from the 
sensor and the sensor was disposed in a biohazard container.  The transmitter was cleaned and 
sterilized according to manufacturer and regulatory guidelines.  The Principal Investigator 
completed training through Medtronic on the proper use and insertion of the device and FDA 
guidelines for care and cleaning.  The device was then downloaded to the manufacturer software.  
Dietary intake and calibration SMBG measurements were recorded in the software. 
  59 
After the first week, an acclimation period commenced for approximately four weeks.  
Throughout this period, the participants were instructed to gradually increase their daily standing 
time to half of their working day and accumulate standing time in intermittent bouts.  After these 
four weeks, the second week of data collection began.  At this time, participants were instructed 
to use their sit-stand desk for at least half of the workday for the next five days.  The CGM was 
inserted again on the first day of the data collection week.  The same procedures for device 
insertion and wearing instructions were followed during the second week of data collection.  
Daily standing time was recorded in the diary in addition to dietary intake, SMBG measurements, 
and physical activity.  One participant was compensated but the others could not accept 
compensation as government employees ($40 for the first CGM and $80 for the second CGM). 
Statistical Analyses 
 Data were analyzed using Microsoft Excel (Windows 2010) and SAS (v9.3).  A linear 
mixed model regression analysis for a crossover design was used in SAS to analyze differences in 
mean blood glucose between the pre-test and intervention weeks.  Working hours (9:00 am to 
5:00 pm) were analyzed to examine the effect of the sit-stand workstation on blood glucose.  
Dietary (i.e., carbohydrate, fat, protein, and fiber intake in grams), physical activity, and 
sedentary time covariates were controlled for in this model.  Results are reported as mean [SD or 
SE] and p-values. 
Results 
   A total of 68 individuals expressed interest in the study (n=62 females and n=6 males).  
Twenty-seven females met eligibility criteria for the study.  The males did not meet inclusion 
criteria.  Data was collected February – July, 2013.  Seventeen participants were lost for multiple 
reasons: (1) four were ineligible; (2) three withdrew; (3) five were not willing to comply with 
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study requirements; and (4) five experienced CGM malfunction during the pre-test and therefore, 
the second test week was not completed.  Participants had impaired fasting glucose and were on 
average overweight or obese.  Table 5-1 summarizes the baseline characteristics of the sample.   
Table 5-1 
Participant Characteristics (n=10) 
Variables         M        (SD)    
  
Age (years)        50.6     (8.5) 
Height (m)        66.2     (2.8) 
Weight (kg)        91.9   (15.6) 
BMI         32.9     (3.9) 
Body fat %
a
        48.7     (4.0) 
SBP       122.3   (11.0) 
DBP         81.9     (7.5) 
Fasting blood glucose (mg/dl)    108.4     (5.6) 
Total cholesterol
a
 (mg/dl)    207.1   (37.6) 
LDL – cholesterola (mg/dl)    121.3   (40.0) 
HDL – cholesterola (mg/dl)      50.9   (14.8) 
Triglycerides (mg/dl)     176.6   (84.1) 
Note.  BMI=Body Mass Index; SBP=Systolic blood pressure; DBP=Diastolic blood pressure; 
LDL=low-density lipoprotein; HDL=high-density lipoprotein. 
a
n=8.   
 
 The self-reported standing time resulted in adherence to standing for approximately half 
of the work day (m = 3.65 ± 0.4 hrs).  The results of the first linear mixed model analysis 
(controlling for the effect of the covariates; carbohydrates, fat, protein, and fiber) indicated a 
nonsignificant effect of standing on blood glucose levels (p = .549) during working hours relative 
to the seated condition (see Table 5-2).  Although the p – value was not significant, the sign of the 
coefficient is in line with the hypothesis that blood glucose would be lower when using the sit-
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stand desk compared to sitting.  In this model, blood glucose in Condition 1 (sitting) was 2.5 
mg/dl higher, on average, than Condition 2 (sit-stand; see Table 5-2).  Carbohydrates, fat, and 
protein (p <.0001) demonstrated a significant effect, although fiber (p = .099) did not.  
Consequently, a one gram increase in carbohydrate or protein produces .08 and .20 mg/dl 
increases in blood glucose, respectively.  In contrast, a one unit increase in fat results in a .19 
mg/dl decrease in blood glucose.   
Table 5-2 
Linear Mixed Model Analysis with Dietary Covariates 
Solution for Fixed Effects 
Effect Cond Estimate    SE DF t Value Pr > |t| 
Intercept   81.6636 3.4869 16 23.42 <.0001 
Condition 1   2.5463 4.1638 16   0.61 0.5494 
Condition 2   0     
Timepoint2     0.09923 0.009395 4255 10.56 <.0001 
Carbohydrates     0.07815 0.01159 4255   6.74 <.0001 
Fat    -0.1924 0.02229 4255  -8.63 <.0001 
Protein     0.2025 0.02319 4255   8.73 <.0001 
Fiber     0.1170 0.07080 4255   1.65 0.0986 
Note. Condition 1 = one week seated pre-test. Condition 2 = one week sit-stand. SE = standard 
error.    DF = degrees of freedom. 
 
 The model was run again including the accelerometer data (KAM points; overall physical 
activity) with similar results (see Table 5-3).  The effect of the intervention increased slightly 
compared to the model in Table 5-2 although there was still not a significant difference between 
conditions.  In this model, overall physical activity is a significant predictor of blood glucose.  
With each one unit increase in KAM points, blood glucose was lowered by .06 mg/dl (p = .017). 
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Table 5-3 
Linear Mixed Model Analysis with Physical Activity as a Covariate 
Solution for Fixed Effects 
Effect Cond Estimate    SE DF t Value Pr > |t| 
Intercept   78.2659 4.3219 14 18.11  <.0001 
Condition 1   3.1264 5.2708 14   0.59  0.5625 
Condition 2   0     
Timepoint2     0.1318 0.01033 3596 12.75  <.0001 
Carbohydrates     0.1024 0.01402 3596   7.30  <.0001 
Fat    -0.2571 0.02922 3596  -8.80  <.0001 
Protein     0.2361 0.02525 3596    9.35  <.0001 
Fiber     0.05043 0.07657 3596    0.66  0.5102 
KAM point   -0.06741 0.02823 3596   -2.39  0.0170 
Note. Condition 1 = one week seated pre-test. Condition 2 = one week sit-stand. SE = standard 
error.    DF = degrees of freedom. 
 Again, the statistical model was run, now including sedentary minutes as a covariate 
(Table 5-4).  The effect on the intervention remained nearly identical to the previous model with 
overall physical activity.  Time spent in sedentary activity significantly predicted blood glucose.  
For every one minute increase in sedentary time, blood glucose increased 0.11 mg/dl (p = .0007). 
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Table 5-4 
Linear Mixed Model Analysis with Sedentary Time Covariate 
Solution for Fixed Effects 
Effect Condition     Estimate         SE DF t Value Pr > |t| 
Intercept            71.8966 4.6740 14 15.38 <.0001 
Condition 1            3.1245 5.3128 14   0.59 0.5658 
Condition 2            0     
Timepoint2              0.1360 0.01045 3596 13.02 <.0001 
Carbohydrates              0.1024 0.01400 3596   7.32 <.0001 
Fat            -0.2557 0.02920 3596  -8.76 <.0001 
Protein             0.2291 0.02535 3596   9.03 <.0001 
Fiber             0.05165 0.07649 3596   0.68 0.4996 
Sedentary min             0.1061 0.03119 3596   3.40 0.0007 
Note. Condition 1 = one week seated pre-test. Condition 2 = one week sit-stand week. SE = 
standard error. DF = degrees of freedom. 
 
 The final model included both overall physical activity and sedentary time (see Table 5-
5).  The treatment effect remained nonsignificant; however, the effect of the intervention 
remained in the hypothesized direction.  Blood glucose was 3.1 mg/dl higher in Condition 1 
(sitting) compared to Condition 2 (standing).  The dietary covariates remain statistically 
significant.  However, with physical activity and sedentary time included in the same model, 
overall physical activity no longer significantly predicted blood glucose.  Sedentary time was 
significantly related to increasing blood glucose, regardless of physical activity (p = .015). 
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Table 5-5. 
Linear Mixed Model Analysis with Physical Activity and Sedentary Time Covariates 
Solution for Fixed Effects 
Effect Cond Estimate         SE DF t Value Pr > |t| 
Intercept   71.5014 5.1636 14 13.85 <.0001 
Condition 1   3.1208 5.3108 14   0.59 0.5661 
Condition 2   0     
Timepoint2     0.1362 0.01048 3595 12.99 <.0001 
Carbohydrates     0.1025 0.01401 3595   7.32 <.0001 
Fat    -0.2557 0.02921 3595  -8.75 <.0001 
Protein     0.2287 0.02541 3595   9.00 <.0001 
Fiber     0.05140 0.07650 3595   0.67 0.5017 
KAM point     0.007521 0.04180 3595   0.18 0.8572 
Sedentary min     0.1123 0.04624 3595   2.43 0.0152 
Note. Condition 1 = one week seated pre-test. Condition 2 = one week sit-stand. SE = standard 
error.    DF = degrees of freedom. 
Discussion 
 Our main finding suggested a trend towards lower blood glucose during the work day 
when these prediabetic adults were using a sit-stand workstation to increase standing time, 
relative to the control/sitting usual workday period. However, this finding was not statistically 
significant, but needs to be followed up with more sophisticated modeling techniques given the 
richness of the dataset.  Sedentary time, however, was a significant predictor of blood glucose.  
The epidemiological literature describes associations of increased sedentary time with risks of 
blood sugar dysfunction regardless of physical activity levels (Dunstan et al., 2005; Dunstan et 
al., 2012; Healy et al., 2008).  The current study objectively demonstrates the deleterious effect of 
sedentary time on blood glucose.  In the final analysis model, sedentary time remains the 
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significant predictor of blood glucose while overall physical activity is no longer predicting blood 
glucose. 
Using the overall mean of the blood glucose readings over the five days may not be a 
good estimate of blood glucose.  Unfortunately, the literature does not provide a standard or 
preferred method of analysis for CGM data and therefore, the current analysis was 
straightforward.  The treatment effect is comparing the average blood glucose of the five days, 
which considerably reduces the degrees of freedom for the effect estimate, and considerably 
increases the magnitude of the standard error.  For this reason, even though the estimated 
difference in daily blood glucose mean was 3.1 mg/dl between conditions, this effect was not 
statistically significant in the present models.  Because glucose fluctuates dramatically throughout 
the day, this may not be the most appropriate analysis technique.  Individuals with impaired 
fasting glucose exhibit more moderate excursions in blood glucose compared to type 1 and type 2 
diabetics.  These excursions may increase the difficulty of finding significant differences, 
especially when broadly estimating the mean.  Varied levels of glucose intolerance between 
participants likely influenced the results as well.  Glucose intolerance across the participants 
ranged from very mild, at the threshold criteria for impaired glucose tolerance, to more severe, 
near the diagnostic criteria for type 2 diabetes.  This wide range of glucose intolerance further 
reduces the ability of the current analysis to detect significant differences.  If the inclusion criteria 
threshold was set at a more conservative 110 mg/dl, this would have resulted in a more 
metabolically homogeneous sample and perhaps would have increased the likelihood of detecting 
significant differences.  Sophisticated analysis techniques are needed to more fully explore these 
CGM data.  Indeed, modest reductions in blood glucose can be clinically meaningful in the 
treatment and management of prediabetes, and the prevention of frank diabetes onset.  Regression 
to normal glucose regulation, even if transient, significantly reduces the risk of future diabetes 
  66 
(Perreault et al., 2012).  Nevertheless, the blood glucose findings in the current pilot study will 
likely serve to be very useful for designing a full-scale study on this and related topics.  
The dietary covariates were also significant predictors of blood sugar.  Increased intake 
of carbohydrates and protein significantly increased blood glucose, whereas, as expected, 
increased fat intake reduced blood glucose.  The effect of carbohydrates and fats are in the 
expected direction.  The positive effect (increasing blood glucose) of protein, however, was 
unexpected, as protein ingestion generally does not increase peripheral glucose (in normal 
individuals; Gannon & Nuttall, 1999).  Further examination of the dietary logs is needed to 
determine the type and quality of protein being consumed as this can greatly affect the rate of 
metabolism (Ten Have, Engelen, Luiking, & Deutz, 2007).  It is also likely that the results for 
protein may be an artifact of the dietary log data or analysis, and this will be explored in more 
detail in future analyses. 
Strengths of the study were the novel use of continuous glucose monitoring technology in 
prediabetic women and conducting the study in a natural setting.  The CGM technology provides 
a large amount of data for each individual and provides valuable data on glucose control.  The 
data can be used to identify problem areas, such as the postprandial period (two to three hours 
after eating), to develop interventions to reduce disease risk and progression.  The study provided 
pilot data to guide future use of CGM in impaired fasting glucose.  No studies to date have 
continuously monitored blood glucose in women with impaired fasting glucose nor has data been 
collected over an entire work week.  Additional strengths were the objectively measured physical 
activity and sedentary time.  Not many studies have captured these variables in the natural setting 
nor has blood glucose been simultaneously monitored in this population. 
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This study has several limitations.  The participants were not randomized to the order of 
the two data collection periods (sitting and sit-stand).  As individuals increase standing while 
working they may experience musculoskeletal discomfort (specifically in the low back and legs) 
due to the increased use of these muscles.  This discomfort generally disappears following a week 
or two of intermittent standing.  The participants may have been less likely to comply to the 
sitting week if they were aware of the discomforts associated with acclimating to the use of the 
desk.  The inclusion criteria for fasting blood glucose was >100 mg/dl.   An increased inclusion 
criteria threshold of >110 mg/dl would result in a metabolically similar sample.  While six men 
volunteered for the study (the male volunteers did not meet inclusion criteria), the participants 
were all women.  This limitation is possibly two-fold in that women are more likely to volunteer 
to participate in research and the worksites consisted of primarily female employees.   
The study recruited a relatively large sample size; however, a number of participants 
were lost following consent.  The continuous glucose monitor involved an invasive procedure in 
addition to monitoring blood glucose daily which led to drop outs.  Others were lost due to the 
monitor malfunctioning.  Five participants had no data upon download following the first week of 
the study.  Because the device was blinded, the malfunction was not known until the transmitter 
was downloaded.  The manufacturer determined the data loss was due to a bad batch of sensors.  
Additional limitations were self-reported dietary intake and standing time.  Nonetheless, the 
participants were instructed to consume a similar dietary pattern during each week while wearing 
the monitor.  Finally, the statistical analysis, as discussed previously, may be a limitation. 
 Future studies should recruit a larger sample size (and minimize loss of participants) and 
recruit from multiple worksites to increase the likelihood of recruiting male participants.  The 
sample size of the current study is fairly consistent with similar studies within the literature, 
considering this area of research is novel (Speck & Schmitz, 2011; Alkhajah et al., 2012; Buckley 
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et al., 2013).  Future studies should examine the long-term effect of reducing sedentary time on 
blood glucose in prediabetes.  Lifestyle interventions (including weight loss, regular physical 
activity, and dietary modifications such as calorie restriction, increased fiber, and limited 
carbohydrate intake) have prevented or delayed progression from prediabetes to type 2 diabetes 
(Garber et al., 2008).  Therefore, reducing sedentary time may be an additional component to 
consider in lifestyle interventions to prevent disease progression. Finally, the effect of the sit-
stand desk on the postprandial period should be examined.  Rather than analyzing the entire work 
day, reducing the analysis period to a specific time point can examine the effect of the 
intervention during a specific time of the work day.   
 Research indicates that sit-stand desks are effective for reducing sedentary time and 
lowering postprandial blood glucose (Alkhajah et al., 2012; Buckley et al., 2013).  However, 
additional research is needed to determine if sit-stand workstations are an effective tool for 
controlling blood glucose and preventing further disease progression in this population.  Long-
term intervention studies with large samples are needed to further examine this research question.   
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6 
The Short-term Effect of Using a Sit-Stand Desk to Reduce 
Sedentary Time in Women with Prediabetes 
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Abstract 
Objective: The primary aim of this study was to examine the acute effect of a sit-stand desk on 
objectively measured sedentary time during the workday among adults with prediabetes.  
Research Design and Methods: The study was a repeated measures pilot study.  All 
measurements were collected at the participant’s worksite and desk under free-living conditions.  
The study included 10 participants who completed the following two conditions: (1) wearing an 
accelerometer and sitting at their desk for one week; and (2) wearing an accelerometer and 
intermittently standing at their desk for one week.  Results: Participants were females who on 
average were overweight or obese and middle-aged.  Participants stood for approximately half of 
the work day during the sit-stand week (m = 3.65 ± 0.4 hrs).  The participants wore an 
accelerometer that tracked minutes spent in three intensity zones (life <2 mph, health 2-4.5 mph, 
and sport >4.5 mph). There was a marginally significant reduction in sedentary time in the 
standing condition compared to the sitting condition.  Mean differences in minutes between the 
zones were as follows; 1.37 ± 2.77, 95% CI [-0.35, 3.08]; 0.55 ± 1.56; [-0.42, 1.52]; and 1.92 ± 
3.44; [-0.21, 4.05] for the minutes in life, health, and life and health zones combined, 
respectively.  Conclusions:  Sit-stand desks may be an effective method for reducing sedentary 
time among adults with impaired fasting glucose.  Further research with a larger sample is needed 
to examine additional benefits associated with reducing sedentary time in this population. 
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Introduction 
Substantial epidemiological and growing experimental evidence support the association 
between sedentary time and cardiometabolic disease (Hamilton, Hamilton, & Zderic, 2007; 
Healy, Matthews, Dunstan, Winkler, & Owen, 2010; Proper, Singh, Van Mechelen, & Chinapaw, 
2011; Wilmot et al., 2012).  Specifically, prolonged sedentary behavior is associated with the 
increased risk of obesity, blood sugar metabolism abnormalities, adverse alterations in 
cardiometabolic markers, certain cancers, and all-cause mortality (Hu, Li, Colditz, Willett, & 
Manson, 2003; Katzmarzyk, Church, Craig, & Bouchard, 2009; Healy et al., 2010; Lynch, 2010; 
Wilmot et al., 2012).  While the epidemiological evidence supporting the association between 
sedentary behavior and adverse health outcomes is vast, the experimental literature has been 
widely lab-based.  There is a need for studies to examining sedentary behavior in free-living 
conditions such as occupational settings.   
Working adults represent half of the world’s population (WHO, 1995).  The majority of a 
working adult’s day is spent performing sedentary behaviors.  Specifically, adults spend an 
average of six hours per work day sitting (Thorp et al., 2009; Ryan, Grant, Dall, & Granat, 2011).  
The simple installation of a height-adjustable workstation has been shown to be effective at 
reducing sitting time both at work and throughout the entire week (Alkhajah et al., 2012).  
Objectively measured activity data demonstrated a reduction in sitting time by 143 minutes per 
working day (Alkhajah et al., 2012).  Neuhaus and colleagues (2014) recently conducted a study 
in which participants were randomly assigned to height-adjustable workstations with a multi-
component intervention (six emails from the staff manager supporting program participation and 
five emails encouraging staff to stand up, sit less, and move around more), height-adjustable 
workstations only, and a comparison group. The workstation plus multi-component intervention 
reduced sitting time by 89 minutes during an eight-hour work day while the group that received 
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the desk only still reduced sitting time by 33 minutes (Neuhaus et al., 2014).  Taken together, 
research indicates that installing a height-adjustable desk is effective for reducing sitting time in 
healthy, working adults.  Height-adjustable desks may be especially important for at risk 
individuals such as those with blood glucose metabolism abnormalities suggestive of prediabetes.  
The effect of height-adjustable desks on sedentary time is yet to be studied in this population.   
Prediabetes affects an estimated 79 million Americans (Centers for Disease Control and 
Prevention [CDC], 2012).  Excessive sitting and sedentary behavior increases the risk of 
developing blood glucose metabolism abnormalities, which often lead to prediabetes and type 2 
diabetes (Healy et al., 2007; Dunstan, Howard, Healy, & Owen, 2012).  Strategies to prevent the 
progression of blood glucose metabolism abnormalities are important given 70% of individuals 
with prediabetes will eventually develop type 2 diabetes (Nathan et al., 2007).  Sedentary 
behaviors that lead to reduced muscle activity such as sitting, watching television, or using a 
computer, are inversely related to insulin action (Dunstan et al., 2007; Healy et al., 2007; Healy et 
al., 2008).  Just one day of sitting reduces insulin action by 39% in healthy men and women 
(Stephens, Granados, Zderic, Hamilton, & Braun, 2011).   
Interventions that reduce sedentary time among prediabetic individuals are needed.  
Working adults spend on average 8.8 hours of their day and one-third of their life at work and 
therefore, the workplace is an optimal location to intervene (Bureau of Labor Statistics, 2012; 
Jans, Proper, & Hildebrandt, 2007). The present study, a repeated measures pilot study, examined 
the acute effect of a height-adjustable workstation on sedentary time among adult females with 
prediabetes.  Participants were employed full-time at a sedentary job.  It was hypothesized that 
participants would exhibit less sedentary time during the week they used the height-adjustable 
desk than the week they used their conventional desk.   
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Methods 
Research Design 
This repeated measures pilot study was conducted at two workplaces in the upper 
Midwest.  The physical activity data presented in this brief report were collected concurrently 
with a blood sugar study and a longitudinal worksite wellness study.  The details of the blood 
sugar study are presented elsewhere (Chapter 5) while the worksite wellness study is currently 
being analyzed.   Measurements were performed at the participant’s desk under free-living 
conditions.   
Participants 
Participants were recruited through flyers and an electronic advertisement on the 
company newsletter.  Employees were invited to attend general information sessions at the 
worksites that included an explanation of the study and question and answer sessions.  A study 
email address was provided for interested participants to contact.  A total of 163 individuals 
(n=144 females; n=19 males) contacted the study email to express interest in the worksite 
wellness study.  Of the 163, 68 individuals (n=62 females; n=6 males) specified additional 
interest in the current study.  A total of 27 female volunteers were initially eligible and recruited 
for the study.  Each participant completed two, one-week conditions while wearing the 
accelerometer.  The two conditions included the following; (1) a pre-test sitting at their desk as 
usual while working; and (2) intermittently standing for half of the work day using a height-
adjustable desk. 
Inclusion criteria included fasting blood glucose greater than 100 mg/dl, a full-time 
employee (defined as working at least 35 hours per week), sedentary workday (75% of their work 
day had to be spent sitting), stable medications for at least six months, and no contraindications to 
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participating in light-intensity physical activity such as standing, walking, or using the stairs.  
Exclusion criteria included a history of heart disease, peripheral artery disease, lower limb 
amputation, known type 1 or type 2 diabetes, renal disease, peripheral neuropathy, retinopathy, 
currently pregnant, active substance abuse, severe visual impairment, hospitalization for a 
psychiatric disorder in the past six months, enrolled in another physical activity study, and the use 
of insulin or an insulin pump.  Each participant completed informed consent and past health and 
medical history was collected.  The study was approved by the University of Minnesota’s 
Institutional Review Board and registered as 1208M18741 at ClinicalTrials.gov. 
Anthropometric and Physiological Measures 
 All measures were collected at the participant’s worksite, in a private setting.  Baseline 
data collection included height and weight, body mass index (BMI), body fat percent (dual energy 
x-ray absorptiometry [DXA]), resting blood pressure (BPTru, BPM-100; BPM Medical Devices), 
fasting cholesterol (Cholestech LDX, Alere), and fasting blood glucose (Bayer Breeze 2; 
Whippany, NJ).   
Activity Measurement 
The Kinetic Activity Monitor (KAM) was worn to measure activity during each one-
week period (Kersh Health, Plano, TX).  The KAM measured minutes of activity in three 
intensity zones; life (<2 mph), health (2-4.5 mph), and sport (>4.5 mph).  The device also 
calculates KAM points.  KAM points are derived from the ratio of the amount of energy used 
while active and the amount of energy used at rest, multiplied by 100% (Kersh Health).  Each 
KAM point represents a 1% increase above basal metabolic rate.  Activity and caloric 
computations are based on height, weight, age, and gender.  The KAM is capable of detecting 
both low and vigorous-intensity activity.  Therefore, low levels of activity associated with 
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moving around one’s desk and office space are detected with this device.  The device can provide 
real-time data on KAM points and minutes of activity at each intensity to participants; however, 
this output was locked during the study in order to blind participants to the data.  Additionally, 
daily physical activity and standing time were recorded on the logs provided to the participants. 
Procedures 
 After attending an information session or viewing one of the study advertisements, 
interested participants contacted the study coordinator via the email provided.  An eligibility 
questionnaire was emailed to the interested participant via SurveyMonkey.  The questionnaire 
determined whether the individual’s job was sedentary and if exclusion criteria were present.  
Once eligible, informed consent was obtained, past medical history was collected, and baseline 
anthropometric data collection commenced.  Data collection was performed at the worksites in 
private rooms.  Participants fasted eight hours prior to data collection.  Fasting blood glucose was 
measured by a finger stick.  The skin was sterilized, lanced, and the first drop of blood was wiped 
away.  A drop of blood was applied to the glucose test strip for the glucometer to analyze (Bayer 
Breeze 2; Whippany, NJ).  Individuals with a fasting blood glucose (FBG) >100 mg/dl were 
eligible to participate in the current study.   
Following anthropometric data collection, participants completed a week long pre-test 
assessment of their sedentary behavior in the seated position.  The KAM was delivered to the 
participant and instructions were given.  The KAM was worn on the front of the pants, in line 
with the knee during waking hours for the entire week (both at work and home).  The KAM was 
not worn while sleeping or during water-based activities.  Daily dietary and activity logs were 
provided for the participant to record all meals, snacks, beverages, and daily physical activity.  A 
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continuous glucose monitor was worn during the same period and procedures and results are 
reported elsewhere (Chapter 5).  The KAM was collected on the last day of the week. 
Following the pre-test, a height-adjustable desk was installed at one worksite and the 
existing motor-driven desks were used at the other worksite.  An ergonomic evaluation was 
completed prior to the use of the desk to inform the participant on proper ergonomics while using 
the sit-stand desk.  An acclimation period of at least three weeks was completed prior to the 
second week of the study.  During this time, the participants were instructed to gradually increase 
their total daily standing time to half of the workday, or approximately four hours.  Participants 
were encouraged to accrue daily standing time through intermittent bouts of standing rather than 
continuous standing.  Participants were instructed to wear proper footwear such as tennis shoes 
and not high heels while standing.  During the second week of data collection the participants 
were encouraged to intermittently stand while working for half of their workday.  The KAM was 
again given to the participant on the first day of the week and collected on the last day.   
Daily standing time was recorded on the logs in addition to dietary intake and physical 
activity.  Participants were instructed to follow similar dietary and physical activity patterns as 
they did during the pre-test.  Following each week of data collection, the KAM was downloaded 
to the software provided by the manufacturer.  The software provided hourly totals for KAM 
points and minutes spent in the life, health, and sport activity zones. 
Statistical Analyses 
 Participant characteristic data were analyzed using SPSS (v21.0) for Windows and 
Microsoft Excel (Windows 2010).  The KAM data was analyzed in Microsoft Excel.  The mean 
difference in minutes between the life, health, and sport zones (minutes) while sitting and 
standing during working hours was computed. Results are reported as mean [SD] and 95% CI. 
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Results 
Participants 
Twenty seven participants enrolled in the study.  However, three withdrew from the 
study, four were ineligible due to meeting exclusion criteria, five chose not to comply with the 
study requirements, and five only completed the first week due to equipment malfunction.  
Therefore, the final sample consisted of 10.  The baseline subject characteristics are presented in 
Table 1.  The participants were on average overweight and obese middle aged females with 
impaired fasting glucose and high triglycerides.  Based on the National Cholesterol Education 
Program’s (Adult Treatment Panel III) guidelines, 50% of the participant’s baseline data met at 
least three of the criteria for the diagnosis of metabolic syndrome (Grundy et al., 2005).  The 
diagnostic criteria include fasting blood glucose (≥110 mg/dl), systolic blood pressure ≥130 
mmHg, diastolic blood pressure ≥85 mmHg, high density lipoprotein (HDL; <50 mg/dl), and 
triglycerides (≥150 mg/dl). 
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Table 6-1 
Participant Characteristics (n=10) 
Variables         M        (SD)    
  
Age (years)        47.3    (9.3) 
Height (in.)        66.2    (2.8) 
Weight (kg)        93.5  (16.2) 
BMI         32.4    (4.4) 
Body fat %
a
        47.2    (6.7) 
SBP       121.9  (11.1) 
DBP         81.7    (7.3) 
Fasting blood glucose (mg/dl)    106.9    (4.1) 
Total cholesterol
a
 (mg/dl)    199.5  (36.1) 
LDL – cholesterola (mg/dl)    113.8  (33.5) 
HDL – cholesterola (mg/dl)      48.5  (12) 
Triglycerides (mg/dl)     186.8  (74) 
Note.  BMI=Body Mass Index; SBP=Systolic blood pressure; DBP=Diastolic blood pressure; 
LDL=low-density lipoprotein; HDL=high-density lipoprotein. 
a
n=8.   
 
Physical Activity 
 Participants self-reported standing time as the daily cumulative total number of hours.  
During the pre-test, participants worked in the seated position as usual and therefore, standing 
time was not reported for this period.  Participants reported standing for approximately half of the 
work day while using the height-adjustable desk (3.65 ± 0.4; n=6).  Differences in the minutes 
spent in the life, health and sport zones between the pre-test and sit-stand weeks during working 
hours were calculated.  The mean differences of the minutes spent in the life, health, and the 
combined mean difference of the life and health zones between the pre-test and sit-stand weeks 
were also calculated.  The differences between the pre-test and the sit-stand week were 
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marginally significant representing a trend toward reduced sedentary time when using the sit-
stand desk (1.37 ± 2.77, 95% CI [-0.35, 3.08]; 0.55 ± 1.56, [-0.42, 1.52]; and 1.93 ± 3.44; [-0.21, 
4.05] for the minutes spent in life, health, and combined life and health zones, respectively).  
Table 6-2 summarizes the findings for the intensity zones. 
Table 6-2 
Accelerometer Intensity Zone Differences (min) During Working Hours 
             95% CI 
                    ______________________ 
Zone        M  (SD)    LL   UL 
Life      1.37  (2.77)   -0.35   3.08 
Health      0.55  (1.56)   -0.42   1.52 
Sport    -0.16 (0.35)   -0.38   0.05 
Life & Health    1.92  (3.44)   -0.21   4.05 
Note.  CI = confidence interval; LL = lower limit; UL = upper limit. 
 
Discussion 
 Increased standing while working through a simple intervention (installing a sit-stand 
desk and encouraging intermittent standing for at least half of the work day) has been previously 
shown to be an effective method for reducing sedentary time in apparently healthy adults 
(Alkhajah et al., 2012).  The present study indicates that a similar outcome can be achieved 
among women with prediabetes.  The self-reported standing time during the sit-stand week 
indicated that participants achieved the goal of standing for approximately half of an 8-hour work 
day while using the sit-stand desk.  The accelerometer results demonstrated a nearly significant 
reduction in sedentary time between when the participants were using their standing instead of 
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their traditional desks.  The marginally significant finding further confirms that the participants 
increased activity during the sit-stand week.  The increase in standing resulted from simply 
installing a desk and providing instruction to gradually increase daily standing to at least half of 
the work day.  The findings are consistent with the current literature on the reduction of sedentary 
time through installation of height-adjustable workstations in healthy adults (Alkhajah et al., 
2012; Neuhaus et al., 2014).  
  Reducing sedentary time at work can lead to improvements in cardiovascular risk and, 
more specifically for this population, reducing the risk of progressing to type 2 diabetes.  
Reducing cardiovascular and diabetes risk is important in this population considering individuals 
with impaired fasting glucose have been found to have similar coronary atherosclerosis and 
plaque vulnerability as those with diabetes (Kurihara et al., 2013).  Therefore, impaired fasting 
glucose, or prediabetes, is a risk factor for coronary artery disease (CAD) itself, which increases 
the necessity and urgency of reducing sedentary time in this population to reduce disease risk.  In 
addition to the increased risk of CAD, half of the participants in the current study meet diagnostic 
criteria for metabolic syndrome. 
 Abdominal obesity and insulin resistance play key roles in the development of the 
metabolic syndrome.  Additional factors implicated in the pathogenesis are a sedentary lifestyle, 
diet, and genetics (Lakka & Laaksonen, 2007)).  An inverse dose-response relationship has been 
found between leisure-time physical activity (LTPA) and metabolic syndrome in middle-age and 
older adults (Halldin, Rosell, de Faire, & Hellenius, 2007).  Based on this relationship, increasing 
LTPA while working is a promising avenue for the prevention and treatment of metabolic 
syndrome in this population.  The precise dose and intensity of activity accumulation while 
working remains unknown; however the simple installation of sit-stand desks appears to be 
helpful for reducing sedentary time.     
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A strength of the study was measuring sedentary time in the natural setting.  Additionally, 
sedentary time at work among adults with impaired fasting glucose has not been examined and 
therefore, this study contributes to a gap in the sedentary and inactivity literature.  Limitations of 
the study include the subjective measurement of standing time and the lack of randomization.  
Participants were not randomly counterbalanced to the two conditions due to the musculoskeletal 
discomfort associated with acclimating to a sit-stand desk.  The discomfort generally disappears 
quickly and may be followed by improvement in chronic low back pain and increased energy 
while working.  If a portion of the participants stood first they would be aware of this acclimation 
period and may be less likely to comply with the sitting protocol due to the perceived benefits of 
standing while working. Another limitation was the small sample size and a significant number of 
participants were lost following consent. The concurrent blood sugar study involved invasive 
blood draw procedures, which contributed to a portion of the drop-out rate.  Additional equipment 
malfunctions (within the blood sugar study) led to further loss.  Another limitation was the 
measurement capability of the KAM. The KAM measures movement in the horizontal plane and 
activity is recorded from movements of the hips and torso.  The KAM is not capable of measuring 
movement in the vertical plane (up and down motions such as transferring from a seated to a 
standing position).  Therefore the device only functions as an accelerometer and not an 
inclinometer.  Finally, the KAM may not have been sensitive enough to detect such minor 
movements as shifting while standing and moving around one’s desk.   
Future studies should use randomization and recruit a larger sample size.  The KAM can 
be an effective tool for promoting physical activity and wellness; however, it is not equipped to 
measure inclinometry.  Therefore, the use of a more sophisticated activity measurement device 
that includes an accelerometer and inclinometer should be utilized in future studies.  The current 
study was conducted over a short period of time.  Future studies should examine the long-term 
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effect of height-adjustable workstations (including biochemical markers such as insulin) in adults 
with prediabetes.  Finally, multicomponent studies that incorporate wellness and physical activity 
education should be conducted. 
Sit-stand desks may be an effective method for reducing sedentary time and combatting 
the deleterious effects of excessive sitting.  The current study extends the knowledge of the 
effectiveness of sit-stand desks to adults with impaired fasting glucose.  Working adults with 
impaired fasting glucose represent a population at high risk for future disease and therefore, 
require innovative interventions that decrease sedentary time to reduce disease risk and 
progression. 
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7 
Summary 
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The purpose of this dissertation was to examine the effect of increased standing at work 
on blood glucose and sedentary behavior among working female adults with impaired fasting 
glucose.  The results presented in Chapters 4-6 provide preliminary pilot data evaluating the 
effect of sit-stand desks on postprandial glucose responses and sedentary time among women at 
risk for developing type 2 diabetes.  This dissertation was novel in three specific ways.  First, the 
effect of standing on glucose responses was evaluated in a natural setting among women with 
impaired fasting glucose.  Previous studies have been conducted in laboratory settings and on 
apparently healthy adults and therefore, there is a need to examine this research question in 
natural settings and in this population.  Second, continuous glucose monitoring technology was 
used to examine the effect of intermittent standing on blood glucose responses.  Blood glucose, 
monitored continuously, during working hours was examined among female adults at risk for 
developing type 2 diabetes.  This technology is primarily used among individuals with type 1 and 
type 2 diabetes.  Therefore, extending its use to prediabetes for potential reduction in disease 
progression is novel.  Finally, examining the effect of a sit-stand desk on decreasing sedentary 
behavior among women with fasting glucose is novel.  Reductions in sedentary time have not 
been specifically examined among this at-risk group.  The results of each paper are summarized 
below.   
The purpose of Specific Aim 1 was to examine the acute effect of a sit-stand desk on 
postprandial glucose in pre-diabetic women.  As described in Chapter 4, postprandial glucose 
increased in the sit-stand desk condition relative to the traditional desk condition.  It is possible 
that stress responses related to standing for an extended period augmented glucose responses.  
Future research following an improved testing protocol is needed to examine the effect of 
intermittent standing on postprandial glucose.  The study should include a larger sample and 
utilize a sit-stand protocol (intermittent standing every 10 minutes rather than continuous 
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standing).  Finally, a mixed-meal beverage should be considered in lieu of the glucose beverage 
to reduce adverse symptoms. 
The purpose of Specific Aim 2 was to assess the effect of a sit-stand desk on blood 
glucose control among pre-diabetic women.  The results presented in Chapter 5 demonstrate a 
trend toward reduced blood glucose while using the sit-stand desk for one week relative to the 
traditional seated position in prediabetic women.  Dietary, physical activity and sedentary time 
covariates significantly predicted blood glucose.  Increased carbohydrate and protein predicted 
increases in blood glucose while fat predicted decreased blood glucose.  In the final analysis 
model, sedentary time was a strong predictor of glucose, not overall physical activity.  Future 
research should recruit a larger sample size and examine the long-term effect of reduced 
sedentary time as a result of using a sit-stand desk on blood glucose regulation in women with 
prediabetes. 
Specific Aim 3 examined the effect of a sit-stand desk on sedentary time among pre-
diabetic women.  The results presented in Chapter 6 suggest that a sit-stand desk may be an 
effective intervention tool for reducing sedentary time in women with prediabetes.  Future studies 
with a larger sample size and additional biochemical measures are needed to further examine the 
effect of sit-stand desks on reducing sedentary time among pre-diabetic women.   
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